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Abstract
Many applications of biomedical science involve unobservable constructs, from measurement of health states
to severity of complex diseases. In this dissertation I utilize joint latent variable methods to combine item
selection and validation to identify significant items in a symptom scale and determine how these symptoms
relate to "gold standard" diagnostic measures. Joint latent variable models eliminate bias inherent in traditional
two-stage methods and provide a global test of the association between the underlying construct and a clinical
measure. In Chapter 1, a review of latent variable methods for multivariate outcomes is provided. Chapter 2
proposes a Multiple Indicator Multiple Cause (MIMIC) model to perform item reduction and validation
simultaneously. A modified Score test for individual factor loadings in the MIMIC model is derived. The
methods are motivated by an example from a premenstrual syndrome (PMS) clinical trial in which one
objective was to determine a reduced number of core symptoms in the diagnosis of severe PMS and to
compare patient-reported symptom information to a clinician-rated "gold standard" diagnostic measure.
Chapter 3 applies an extension to the MIMIC model to patient-reported outcomes (PROs) from the Physical
Activity and Lymphedema (PAL) clinical trial. PROs are a potentially less expensive and time-consuming
measure of diagnosis than some clinical measures. An extension of the MIMIC model for ordered categorical
outcomes determines which symptoms are important indicators of lymphedema and how these symptoms
compare to clinical endpoints. Finally, in Chapter 4, a multivariate zero-inflated proportional odds (MZIPO)
model is proposed to account for excess symptom non-response at baseline. This model adds a latent class
component to the traditional MIMIC model. The MZIPO model is applied to the PAL data to obtain more
accurate estimates of the latent construct and its association with current measures of lymphedema severity.
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ABSTRACT
WRESTLING WITH ISSUES IN SCALE DEVELOPMENT USING JOINT
LATENT VARIABLE METHODS
Steffanie M. Halberstadt
Mary D. Sammel, Advisor
Many applications of biomedical science involve unobservable constructs, from mea-
surement of health states to severity of complex diseases. In this dissertation I utilize
joint latent variable methods to combine item selection and validation to identify
significant items in a symptom scale and determine how these symptoms relate to
“gold standard” diagnostic measures. Joint latent variable models eliminate bias
inherent in traditional two-stage methods and provide a global test of the associ-
ation between the underlying construct and a clinical measure. In Chapter 1, a
review of latent variable methods for multivariate outcomes is provided.
Chapter 2 proposes a Multiple Indicator Multiple Cause (MIMIC) model to
perform item reduction and validation simultaneously. A modified Score test for
individual factor loadings in the MIMIC model is derived. The methods are moti-
vated by an example from a premenstrual syndrome (PMS) clinical trial in which
one objective was to determine a reduced number of core symptoms in the diag-
nosis of severe PMS and to compare patient-reported symptom information to a
clinician-rated “gold standard” diagnostic measure.
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Chapter 3 applies an extension to the MIMIC model to patient-reported out-
comes (PROs) from the Physical Activity and Lymphedema (PAL) clinical trial.
PROs are a potentially less expensive and time-consuming measure of diagnosis than
some clinical measures. An extension of the MIMIC model for ordered categorical
outcomes determines which symptoms are important indicators of lymphedema and
how these symptoms compare to clinical endpoints.
Finally, in Chapter 4, a multivariate zero-inflated proportional odds (MZIPO)
model is proposed to account for excess symptom non-response at baseline. This
model adds a latent class component to the traditional MIMIC model. The MZIPO
model is applied to the PAL data to obtain more accurate estimates of the latent
construct and its association with current measures of lymphedema severity.
Key Words: Factor analysis, Latent class, Latent variable, Multiple indicator mul-
tiple cause, Multivariate, Zero-inflation.
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Chapter 1
Introduction
Many applications of biomedical science involve unobservable constructs, from the
measurement of health states to the severity of complex diseases. From a statisti-
cal perspective, the goal of measurement is often to combine important pieces of
information in a way that thoroughly describes an unobservable construct.
In the scale development process, item selection or reduction determines which
items best exemplify the construct of interest. It is undesirable to include “junk”
items, any items that fail to contribute useful information about the hypothetical
construct, because they obscure the final scale score. The process of removing un-
necessary items ultimately improves scale accuracy, reduces burden to participants,
and decreases research costs. Next, validation establishes the relationship between
a particular scale and other measures of the unobservable concept of interest. Typ-
ically item selection and validation are performed separately using methods from
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psychometric research. Joint latent variable methods are proposed here to combine
item reduction and validation into a single statistical model.
This dissertation is presented as an illustration of the advantages of joint latent
variable models and as an example of the applicability of these models to biomedical
research. The methods are applied to data from innovative clinical trials in women’s
health. The first application involves the Penn Daily Symptom Report from a
clinical trial for premenstrual syndrome (PMS) at the University of Pennsylvania.
The second application involves the Norman Lymphedema Survey from the Physical
Activity and Lymphedema (PAL) clinical trial at the University of Pennsylvania.
Both motivating examples seek to evaluate current diagnostic tools and incorporate
patient-reported symptom information into the diagnostic process.
1.1 Motivation: Symptom Scale Data in Clinical
Trials
PMS
PMS is described as a collection of physical and emotional symptoms that
present at the luteal phase of the menstrual cycle. Over 200 symptoms of PMS
have been previously identified, yet there is no universal diagnosis criteria. There-
fore, a variety of “gold standard” measures are used to diagnose PMS. Some include
summary measures from patient-reported daily symptom diaries, while others are
2
based on clinician ratings of PMS severity. In Chapter 2, I identify and evaluate a
core set of symptoms from a larger battery to thoroughly describe severe PMS and
establish criterion validity by comparing this reduced set of symptoms to a “gold
standard” diagnostic measure of PMS using data from a University of Pennsylvania
PMS clinical trial directed by Dr. Ellen Freeman.
Lymphedema
For breast cancer survivors, lymphedema is a debilitating chronic condition re-
sulting from the surgical excision of lymph nodes as part of cancer treatment. Its
significant impact of daily functioning and quality of life makes lymphedema a se-
rious concern for women recovering from breast cancer. Similar to PMS research, a
complication in the study of lymphedema is that the estimates of incidence among
breast cancer survivors in the literature vary dramatically, ranging from as small
as 6% to as large as 70%. This discrepancy is likely due to the variety of diagnos-
tic measures that are used, many of which may not necessarily capture the same
attributes of lymphedema. Furthermore, patient-reported symptoms that could
potentially prove useful as indicators of lymphedema are not typically used as diag-
nostic measures. The objective of Chapter 3 is to determine which items from the
Norman Lymphedema Survey are the most important indicators of lymphedema
and whether they perform as well as current “gold standard” diagnostic measures.
Chapter 4 focuses on how to identify important lymphedema symptoms while si-
multaneously accounting for significant symptom non-response at baseline.
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1.2 Latent Variable Models for Multivariate Out-
comes
Although latent variable models originated in psychometrics and education research,
their utility has increased recently in biomedical research. The following literature
review provides a general overview of classic latent variable methods.
A latent variable is defined as a random variable that cannot be directly mea-
sured and instead is inferred through the measurement of other observable variables.
Latent variables often represent underlying constructs that are difficult or impossi-
ble to quantify. The use of latent variables in the study of immeasurable constructs
is extensive in education, psychometrics, and econometrics. For example, latent
variable models are used in scale development and revision for high-stakes edu-
cational assessment; scales assessing constructs such as personality, happiness, or
depression; and as a representation for paradigms like permanent income. Recent
examples of biomedical applications for latent variable models include research on
diagnostic tests, health-related quality of life scales, and even genetics. These mod-
els are flexible in that they accommodate a variety of observed response types and
different types of latent variables. They provide a means of aggregating multiple
observed variables in a single model and relating them to an intangible construct.
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1.2.1 Latent Variable Models for Continuous Observed Out-
comes
Factor analysis and structural equation models are two popular latent variable
models for multivariate continuous observed variables. Used to describe variability
among a set of continuous observed variables, the factor analysis model separates
variance among observed variables into variance due to a common factor, or un-
observed latent construct, and the residual variance due to the specific observed
manifest variables. The classic factor analysis model assumes the latent variable is
a continuous, normally distributed random variable. Observed variables are mod-
eled as a linear combination of latent factors and error terms for specific variance.
Factor analysis is commonly used to determine which items are the strongest in-
dicators of a particular construct. Factor loadings, the parameters of interest in
the factor analysis model, measure the association between an item and the latent
factor. Large standardized factor loadings are desired because they indicate that
the item is strongly associated with the underlying construct. Other measures in-
volving factor loadings can also help to determine the value of an item, such as
the proportion of variance in the outcome explained by the latent variable. This
measure can be calculated for each item and provides an estimate of the item’s
importance in a manner not dependent on the scale.
Factor analysis can be exploratory or confirmatory in nature, and the difference
lies in the assumptions made about the structure of the latent factors. Exploratory
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factor analysis (EFA) identifies the number and nature of the factors. The ultimate
purpose of factor analysis is often to reduce the number of observed variables, so
EFA is a natural choice for item selection. Confirmatory factor analysis (CFA)
serves as a separate validation procedure once the factor structure has been estab-
lished. CFA differs from EFA in that it allows for more constraints on the factor
structure. For example, in multifactor CFA models, a “clean” solution is frequently
assumed where certain factor loadings are set to zero such that each manifest vari-
able loads on only one latent factor. In the methods developed in Chapter 2 and
applied in Chapter 3, a CFA model is one of two components of a joint latent
variable model developed for item selection and validation.
Structural Equation Modeling
Structural equation modeling extends the factor analysis model to include structural
relations among latent variables as well as covariates on latent or observed variables.
Originally developed for continuous observed outcomes, structural equation models
(SEMs) are two-part models containing both a measurement and a structural model.
The measurement model is simply a CFA model with one or more continuous latent
variables measured by several continuous items. The structural model specifies
associations of latent variables with other observed or potentially latent variables.
SEMs feature both latent exposure variables and latent outcome variables, as well as
observed exposure and outcome variables. Structural relationships among the latent
variables may be formulated as a regression relationship or in terms of correlated
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residuals among the latent variables. The models proposed in Chapter 2 can be
thought of as an example of an SEM with a single latent variable.
1.2.2 Latent Variable Models for Categorical Observed Out-
comes
Latent Class Models
A common latent variable for categorical observed outcomes, the latent class
model classifies subjects into unobserved subgroups. In comparison to latent vari-
able models with continuous latent variables like the factor analysis model or SEM,
the latent class model contains a discrete latent variable with C categories. Useful
for describing population heterogeneity, latent class models assume that any ob-
served responses originate from an underlying discrete latent class. These models
have particular relevance to clinical studies because diagnostic decisions can po-
tentially be made based on subgroup classification. In Chapter 4, a latent class
component is incorporated into the model to classify subjects into subpopulations
based on symptom response or non-response.
1.2.3 Extensions to Classical Latent Variable Models
The models presented above represent the most basic latent variable models that
set the foundation for the many advanced latent variable models that have been de-
veloped over the past several decades. Extensions to classical models have been for-
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mulated for a variety of response types including multilevel, longitudinal, survival,
or mixed outcome types. Of particular relevance to this dissertation is the class of
latent variable models known as latent variable hybrid models. The confluence of
a continuous latent variable model and a latent class model, these models accom-
modate both cross-sectional and longitudinal outcomes and allow for covariates.
Crucial features of these models are that they allow for classification of subjects
into unobserved subgroups and also provide factor scores, estimates of the latent
variable, within the subgroups. In this dissertation I extend the latent variable
hybrid literature in the situation of zero-inflated outcomes.
The remainder of the dissertation is structured as follows: Chapter 2 presents
a joint latent variable model for continuous data. A multiple indicator multiple
cause model is employed to perform item reduction and validation simultaneously,
and a modified Score test for individual factor loadings is developed. This work is
illustrated with an example from a University of Pennsylvania PMS clinical trial.
Chapter 3 presents an application of an extension to the MIMIC model for ordered
categorical outcomes and is illustrated with an example from the PAL clinical trial.
Chapter 4 proposes a new joint latent variable model for item reduction and valida-
tion in the presence of zero-inflation, which is also applied to the PAL data. Finally,
Chapter 5 presents conclusions and future work.
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Chapter 2
A Joint Latent Variable Model for
Item Reduction and Validation
using Continuous Scale Items
2.1 Introduction
This chapter presents a joint latent variable approach to item reduction and vali-
dation for continuous data. I employ a multiple indicator multiple cause (MIMIC)
model with the objective of identifying important items in a symptom scale and
comparing these items to a physician-rated “gold standard” diagnostic measure.
The methods in this chapter are illustrated with an example from PMS.
Methods for item reduction originated in psychometrics and education where
9
constructs such as depression and intelligence provided motivation for the develop-
ment of measurement techniques to quantify and explain these entities via multiple
items in a scale. The literature in these fields offers a variety of latent variable
methods that utilize the correlation among items to define a construct. Classical
test theory (CTT), a popular psychometric method for item selection, employs mea-
sures such as item-total correlations and Cronbach’s alpha to judge items (Nunnally
et al., 1967; Clark and Watson, 1995). Item-total correlation measures the corre-
lation of a particular item with the scale total when that item is omitted from the
scale. High item-total correlations are desired and it is advised that items whose
item-total correlation is less than 0.2 be dropped from the scale (Streiner and Nor-
man, 1994). Cronbach’s alpha is another popular measure of reliability and it is
often advised that alpha be between 0.7 and 0.9. Values of alpha below 0.7 indicate
that the items may not be homogeneous and values above 0.9 can be indications of
several problems with the scale, such as item redundancy or the presence of more
than one distinct construct.
Perhaps the most common statistical model for item reduction is the factor anal-
ysis model (Spearman, 1904). As described in Chapter 1, the model separates the
variance among a set of observed variables into variance due to a latent factor and
variance due to individual observed variables. Item reduction in factor analysis is
done by evaluating factor loadings across multiple factors or analyzing the loadings
within a particular factor. Factor loading parameters yield information about the
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strength of the relationship between an individual item and the underlying con-
struct.
Creating decision rules presents a unique challenge in item selection. Although
many arbitrary rules exist, there seems to be little quantitative justification for what
constitutes a sufficiently high factor loading, item-total correlation, or Cronbach’s
alpha. I focus on factor loadings as a primary measure of interest because they are
natural measures of the contribution of an item to the latent construct.
Item selection in factor analysis is performed by assessing the magnitude of factor
loadings, but a challenge is determining when they are sufficiently large. A review
of the literature reveals many different methods, some of which are contradictory
to one another. Shortly after the development of factor analysis, Thurstone (1938)
proposed to interpret factor loadings on the correlation scale greater than 0.40 as
significant and to disregard loadings less than 0.20. Comrey and Lee (1992) offered
the following scale: loadings greater than 0.71 are excellent, 0.63 are very good, 0.55
are good, 0.45 are fair, and loadings less than 0.32 are poor. More recently, several
authors suggested treating loadings greater than 0.30 as significant (Tabachnick
et al., 2001). Cudeck and O’Dell (1994) mentioned that it is common in factor
analysis studies with more than one factor to examine the loadings for each item,
choose the largest one for each item and disregard the others in order to obtain
a “clean” solution. Similarly, Clark and Watson (1995) suggested that items that
load highly on the first factor and weakly on subsequent factors are ideal candidates
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for consideration and should be chosen after a further correlational and reliability
analysis is performed to identify redundant pairs of items. Clearly there is little
agreement on what constitutes a significant loading. Furthermore, papers that
suggest reference values generally do not provide justification for these choices.
In an effort to make the process of analyzing factor loadings more statistically
rigorous, standard errors for factor loadings have been derived to allow for the assess-
ment of variance in the estimated loadings. Lawley and Maxwell (1962) developed
asymptotic variances and covariances for unrotated factor loadings for maximum
likelihood factor analysis. Subsequently, formulas for various types of unrotated
(Jennrich, 1974; Jennrich and Thayer, 1973) and rotated (Archer and Jennrich,
1973; Jennrich and Thayer, 1973; Jennrich, 1974; Cudeck and O’Dell, 1994) load-
ings were developed. There is a substantial amount of literature devoted to the
topic of standard errors in factor analysis and structural equation models given
varying assumptions about the distribution of the data, the number of underlying
factors and whether the loadings are rotated or unrotated.
Cudeck and O’Dell (1994) proposed one of the few methods of developing a
statistical test using standard errors of factor loadings. They provided a thorough
review of methods for estimating standard errors and provided some new results for
standard errors of rotated loadings. Ogasawara (1996, 1998, 1999) provided stan-
dard error estimates for orthomax, promax, and procrustes rotations in a method
similar to Jennrich (1974) assuming normality and using an augmented information
12
matrix. Using a new approach, Hayashi and Kumar Sen (1998) found a matrix form
for the covariance matrix of factor loading estimates under the normality assump-
tion. Furthermore, Hayashi and Yung (1999) developed standard errors for factor
loadings with an orthomax rotation using the delta method. In addition to the de-
velopment of standard errors in the case of normal data, Yuan et al. (2002) reviewed
standard errors for factor loadings in the presence of missing data, non-normal data,
and outliers.
Unfortunately, in most studies that employ factor analysis as a main statistical
method, the use of standard errors in determining the significance of factor loadings
is far less popular than other ad hoc techniques. Furthermore, conventional Wald
tests using the standard errors are not always valid. In the model presented in
this chapter, factor loadings were required to be non-negative so that items only
contributed positively to the estimate of the latent variable. Consequently, the
statistical test of a factor loading amounted to a test of a variance component on
the boundary of the parameter space. The traditional Wald test was no longer
appropriate in this case. This issue is described in detail in Section 2.2.
Once the selection of important items is complete, a process of validation deter-
mines how well the scale measures the intended construct of interest. Establishing
validity in scale development can be performed in a number of ways, including
comparing the model to other models measuring the same construct or comparing
a single model on different samples. In this dissertation, establishing criterion va-
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lidity was desired. Streiner and Norman (1994) describe criterion validity as the
correlation of a scale with another measure of the underlying construct, such as a
“gold standard” that has been previously studied or is accepted in the field. Fre-
quently, validation is performed separately from item selection. Unfortunately, the
two-stage procedure of item selection and validation ignores additional measure-
ment error inherent in the estimation of the factor (Sammel and Ryan, 1996). In
comparison to other approaches such as a multivariate linear mixed model, there is
evidence that a two-stage approach leads to bias toward the null.
A structural equation model can be used to combine item selection and vali-
dation. It is not only possible to model the association between items and a la-
tent construct but also associations between the validation measure and individual
items. To explore the efficiency of performing item selection and validation in a
single model, I employed a MIMIC model (Joreskog and Goldberger, 1975) in this
chapter. This flexible model is an example of a general structural equation model
with one latent variable. As in factor analysis, factor loading estimates from the
model provide information on how closely the items are correlated with the latent
construct. Additionally, information about the relationship between the items and
the validation metric is revealed through the regression parameter on the latent vari-
able. In order to identify unimportant items, I developed a univariate Score test
for estimated factor loadings of the MIMIC model. There are several advantages
to this model. First, validation is incorporated directly into model development as
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opposed to CTT, IRT, or simple factor analysis models where validation occurs as
in a second stage. Second, the statistical test of individual factor loadings derived
here reflects the assumed model constraints.
A University of Pennsylvania PMS clinical trial was considered as a motivating
example. The MIMIC model allowed for both the identification of symptoms from
a scale that were ultimately important contributors to a latent measure of PMS
severity and the comparison of this core set of symptoms to the “gold standard”
diagnostic measure. The primary aim was to produce a clinically relevant set of
symptoms that discriminated subjects with severe PMS from those without.
The remainder of this chapter is outlined as follows. Section 2.2 illustrates
the MIMIC model and describes model constraints, Section 2.3 describes the PMS
clinical trial, Section 2.4 presents results of the PMS example, Section 2.5 presents
simulations and results, and Section 2.6 describes our conclusions.
2.2 Methods
An extension to the factor analysis model, the MIMIC model consists of a system
of structural equations including both observed indicators and observed causes of a
hypothesized latent variable. Observed indicators are random variables assumed to
have been generated by the latent variable, similar to the items or manifest variables
in a factor analysis model. Observed causes are either fixed or random variables that
influence the latent variable, similar to covariates in a regression setting. The single
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latent variable is measured by the set of observed indicators and is regressed on the
set of observed causes (Zellner, 1970; Hauser and Goldberger, 1971; Sammel and
Ryan, 1996). Sammel and Ryan (2002) demonstrate that a test of the regression
parameter is a global test of the observed cause on all observed indicators. The
MIMIC model can be considered an extension to the factor analysis model because
it allows for the inclusion of covariates that serve to validate the latent variable. The
model also measures the relationship between covariates and indicator items through
the latent variable. In the motivating example, the MIMIC model is formulated such
that the single latent variable is interpretable as a continuum of PMS severity. It is
natural to constrain factor loading parameters to be non-negative so that each item
is a positive addition to the severity score. Allowing negative factor loadings would
obscure the interpretation of the severity score allowing it to be a combination of
positive and negative standardized items.
A modified Score test was developed to evaluate the significance of individual
factor loadings of the MIMIC model under model constraints. Unlike traditional
ad hoc methods of assessing factor loadings, this statistical test was chosen because
it not only accounts for the estimate of the factor loading but also for its variance.
A Score test was chosen over a Wald test provided by standard software because
a Wald test is no longer appropriate given the model was constrained to allow for
positive factor loadings only. Because of this constraint, the test is considered a
test of a variance component on the boundary of the parameter space. Details of
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the Score test are described below.
2.2.1 MIMIC Model Specification
There are two components to the general MIMIC model: a measurement model
that specifies the factor analysis model and a structural model that specifies the
regression of the latent variable on the observed causes (see Figure 2.1). Consider a
sample of n individuals from whom a set of m outcome measurements, yi1, ..., yim,
and one validation measurement, zi, are taken. The MIMIC model is written as
follows. For subject i = 1, ..., n and outcome measurements j = 1, ..,m the mea-
surement model is specified as
yi(m×1) = µ(m×1) + λ(m×1)bi(1×1) + i(m×1) (2.2.1)
where µ is a vector of means, λ is a vector of factor loading parameters, bi is the
latent variable, and i is a vector of specific variances. The structural model with
a single “gold standard” is specified as
bi(1×1) = β(1×1)zi(1×1) + δ(1×1) (2.2.2)
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where β is the regression coefficient for the “gold standard” and δ is an error term
for the latent variable. Additional assumptions include
E() = 0, Cov() = Ψ, Cov(b, ) = 0, E(δ) = 0,
V ar(δ) = σ2, Cov(δ, z) = 0, Cov(δ, ) = 0, Cov(z, ) = 0
where Ψ is a diagonal matrix. This model assumes that the error terms in the
measurement model are uncorrelated with the observed causes in the structural
model and with the error term in the structural model. Additionally, the error
term in the structural model is uncorrelated with the observed causes. Equations
(2.2.1) and (2.2.2) imply the following marginal model for yi
f(yi|µ,λ, β,Ψ) ∼MVN(µ+ λβzi,Σ = λλ> + Ψ). (2.2.3)
Additionally, the constraint that each of the factor loadings must be non-negative,
i.e., λj > 0, is placed on the model.
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Figure 2.1: Path diagram of general MIMIC model for m continuous observed
indicators and one observed cause. Boxes denote observed variables and oval denotes
latent variable.
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2.2.2 Likelihood and Score Function
For the set of parameters θ = (µ,λ, β,Ψ)>, the log-likelihood for the model from
Equation (2.2.3) is expressed as
lnL(y;θ) =
np
2
ln (2pi)− n
2
ln (|Σ|)
−1
2
n∑
i=1
[{yi − (µ+ λβzi)}>Σ−1{yi − (µ+ λβzi)}]. (2.2.4)
Taking the partial derivative of the log likelihood with respect to λ, the vector of
factor loadings, yields the following portion of the score function
Uλ =
∂l(y; θ)
∂λ
= −n
2
[2Σ−1 −Σ−1 ◦ Im] ? [E(m,1)λ> + Im ⊗ λ]
−1
2
n∑
i=1
2[Σ−1βzi{yi − (µ+ λβzi)}
−{((yi − (µ+ λβzi))> ⊗ Im)(Σ−1 ⊗ Im)×
(E(m,1)λ
> + Im ⊗ λ)Σ−1(yi − (µ+ λβzi)}] (2.2.5)
where (Σ−1 ◦ Im) denotes the elementwise Hadamard product (Styan, 1973). The
star product, ? , is used as in MacRae (1974), and E(m,1) refers to a permuted
identity matrix (Rogers, 1980). The Fisher information matrix was derived by
evaluating the negative expectation of the matrix of second partial derivatives. The
information matrix was simplified by assuming the null hypothesis H0 : λj = 0 was
true.
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2.2.3 Score Test
The strength of the relationship between each observed indicator and the underlying
latent construct was evaluated by testing each of the factor loadings in the MIMIC
model. The null hypothesis can be written as
H0 : λj = 0|µ, β,Ψ,λj 6=k. (2.2.6)
The Score test for the null hypothesis resulted in the univariate test statistic
Tλj = U
2
λj
(0)Vj,j|β=βˆ,µ=µˆ,Ψ=Ψˆ,λj 6=k=λˆj 6=k , (2.2.7)
where U2λj(0) is the square of the score function of λj evaluated under the null
hypothesis and Vj,j is the element of the inverse of the Fisher information matrix
corresponding to λj evaluated under the null hypothesis. The parameters βˆ, µˆ, Ψˆ
and λˆj 6=k were estimated using maximum likelihood.
Because of the constraint that λj must be non-negative, the parameter space
for λj was [0,∞). The test of H0 : λj = 0 was considered a test of a variance
component on the boundary of the parameter space. Therefore, a one-sided Score
test that did not have the traditional chi-square distribution was used (Zhang and
Lin, 2008). The asymptotic null distribution of the test statistic was a mixture of
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chi-square distributions; that is,
P (Tλj > c|H0) =
1
2
P (χ21 > c) +
1
2
P (χ20 > c) (2.2.8)
(Verbeke and Molenberghs, 2003, p. 256). Testing each of the factor loadings
allowed for the assessment of whether an item appeared to be uncorrelated with
the latent variable and could be considered for removal from the scale. In order
to develop a Score test for the MIMIC model, the score function and information
matrix of the MIMIC model were derived (see Appendix A) and SAS 9.2 IML was
used to evaluate the inverse of the information matrix.
2.3 Application to Premenstrual Syndrome Clin-
ical Trial
Currently, there is little consensus among the medical community regarding a defi-
nition of PMS. There are differences in the diagnostic criteria given by the American
College of Obstetricians and Gynecologists, the World Health Organization, and the
American Psychological Association. A literature review found over 200 symptoms
cited as indicators of PMS. One aim of a University of Pennsylvania PMS clinical
trial was to reduce the set of symptoms in the Penn Daily Symptom Report (DSR),
a validated scale that measures the severity of 17 PMS symptoms (Freeman et al.,
1996). Item reduction was an important step in determining a symptom profile for
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PMS that discriminated well among patients with differing levels of severity. Fur-
thermore, identifying the core symptoms that describe severe PMS could be useful
in clinical practice, but only if symptoms could be shown to be as effective a means
of diagnosis as the current “gold standard” diagnosis for severe PMS. Traditional
methods (factor analysis, IRT models) base selection on the correlations among a
set of variables and do not consider how the proposed latent constructs relate to
a “gold standard” or other known variables. It is proposed here that better con-
structs are developed by combining the identification and validation stages into a
joint model.
The sample for the study came from N = 684 women with complete data who
participated in one of three similar PMS clinical trials at the University of Pennsyl-
vania between 1994 and 2007. Women sought medical treatment for PMS symptoms
and were screened for inclusion in the trials. The data presented here came from
the screening pre-treatment portion of the trials, which included three standard-
ized menstrual cycles for each woman. PMS symptoms were measured using the
DSR. Each symptom was measured on a 5-point Likert scale from 0 = None to 4
= Severe. Symptoms included irritability/anger, mood swings, anxiety/tension,
depression, feeling out of control, feeling worthless/guilty, decreased interest in
usual activities, poor coordination, insomnia, difficulty concentrating/confusion,
fatigue, aches, headache, cramps, breast tenderness, swelling/bloating, and food
cravings/increased appetite. The scale aimed to measure several domains of symp-
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tom severity, including physical, emotional, and behavioral. Premenstrual symptom
scores were calculated by summing the daily symptom score over the 6-day premen-
strual period for each symptom and were treated as normally distributed continuous
measures.
The “gold standard” severe PMS outcome measure was created using data from
the second untreated menstrual cycle. A woman was considered to have severe PMS
based on her scores of the clinical global impression (CGI) scale (Guy, 1976). CGI
is reported as a secondary outcome in many clinical trials of PMS (Freeman et al.,
1999, 2001, 2004) and incorporates a variety of information into a single global
measure meant to reflect the overall status of the patient. CGI is measured on
a Likert scale with seven categories with higher scores indicating greater severity.
PMS diagnosis was based on having a CGI score of five or greater. In the MIMIC
model analysis, this “gold standard” PMS diagnosis served as the observed cause
and the 17 summed DSR symptom scores served as the observed indicators. We as-
sumed V ar(δi) = 1, allowing the latent variable to be interpreted on a standardized
scale. All analysis was performed on the covariance scale, not the correlation scale.
Parameter estimates for the MIMIC model were obtained using PROC CALIS in
SAS 9.2.
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2.4 Results
The prevalence of PMS as measured by the “gold standard” was about 70% in the
sample (N = 476). For the full sample, mean item DSR scores ranged from 4.45
for cramps to 12.28 for anxiety (See Table 2.1). Generally larger mean DSR scores
were found among mood items, including irritability (mean DSR = 12.17) and
mood swings (mean DSR = 12.10). Smaller average DSR scores were found among
physical symptoms, such as headaches (mean DSR = 5.70) and lack of coordination
(mean DSR = 5.06). There were significant differences in the symptom means
between those with severe PMS and those without across all 17 symptoms. Average
DSR scores were significantly greater in the severe PMS group. When considered
individually, all symptoms were significantly associated with the “gold standard”
in univariate linear regressions (p<0.0001 for all).
Correlations among all items were moderate, ranging in size from ρ=0.233 be-
tween anxiety and cramps to ρ=0.791 between anxiety and irritability. The largest
correlations were found among mood items, while the correlations between mood
and physical items tended to be smaller. In general, correlations between two phys-
ical items were not as large as the correlations between two mood items.
Table 2.2 provides standard psychometric measures for DSR items. Item-total
correlations ranged in magnitude from 0.467 for breast tenderness to 0.749 for mood
swings. According to the 0.2 criteria (Streiner and Norman, 1994) none of the items
were immediately be candidates for removal. All Cronbach’s alpha values were
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Table 2.1: Descriptive statistics of Daily Symptom Report stratified by PMS diag-
nosis.
Full Sample PMS No PMS
(N=684) (N=476) (N=208)
Symptom Mean SD Mean SD Mean SD P
Fatigue 11.25 6.193 13.116 5.743 6.981 4.955 <0.0001
Poor Coordination 5.063 6.187 6.347 6.656 2.125 3.494 <0.0001
Hopeless 9.958 6.785 12.013 6.332 5.255 5.286 <0.0001
Guilty 7.202 6.845 8.884 6.972 3.351 4.653 <0.0001
Headache 5.703 5.909 6.857 6.183 3.063 4.174 <0.0001
Anxiety 12.279 6.467 14.319 5.761 7.611 5.509 <0.0001
Aches 7.297 6.798 8.721 6.967 4.038 5.078 <0.0001
Irritability 12.165 6.374 14.143 5.750 7.639 5.351 <0.0001
Mood Swings 12.095 6.730 14.275 5.980 7.106 5.608 <0.0001
Weight Gain 11.133 7.093 12.868 6.809 7.163 6.070 <0.0001
Food Cravings 10.994 6.922 12.710 6.761 7.067 5.559 <0.0001
No Interest in Activities 8.444 6.906 10.391 6.783 3.990 4.812 <0.0001
Cramps 4.446 5.964 5.361 6.43 2.351 4.016 <0.0001
Depression 9.921 6.970 11.918 6.731 5.351 5.117 <0.0001
Breast Tenderness 8.558 7.485 9.849 7.680 5.606 6.078 <0.0001
Insomnia 7.171 6.931 8.578 7.184 3.952 5.011 <0.0001
Difficulty Concentrating 7.950 6.858 9.754 6.893 3.822 4.643 <0.0001
similar to one another and all exceeded 0.9. Although this is a common occurrence,
it could indicate the presence of item redundancy.
Table 2.3 displays the results of the full MIMIC model for all 17 symptoms.
Estimates of factor loadings, on the covariance scale, ranged from 2.14 for cramps to
4.45 for mood swings. As seen in previous results, estimates for anxiety, irritability
and mood swings were larger than the estimates for many of the physical symptoms.
The estimate of the regression coefficient on the latent variable, βˆ, was 1.55. This
estimate can be interpreted as the mean of the latent variable, PMS severity, for
subjects with diagnosed severe PMS according to the “gold standard” measure. The
latent variable was standardized such that V ar(δi) = 1, which implies that subjects
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Table 2.2: Standard psychometric measures of item selection for DSR symptoms.
Symptom Item-Total Correlation Cronbach’s Alpha
Fatigue 0.7083 0.9243
Poor Coordination 0.6538 0.9256
Hopeless 0.7208 0.9240
Guilty 0.6468 0.9258
Headache 0.5024 0.9292
Anxiety 0.7103 0.9242
Aches 0.5845 0.9273
Irritability 0.7173 0.9241
Mood Swings 0.7491 0.9233
Weight Gain 0.6167 0.9265
Food Cravings 0.5802 0.9274
No Interest in Activities 0.7251 0.9239
Cramps 0.4782 0.9298
Depression 0.6956 0.9246
Breast Tenderness 0.4666 0.9301
Insomnia 0.5782 0.9274
Difficulty Concentrating 0.7151 0.9241
without severe PMS had a mean latent severity score of 0.
Table 2.3: Full MIMIC model for continuous items applied to PMS data.
Symptom λˆj Tλj Corrected P
Fatigue 3.631 127.009 <0.0001
Poor Coordination 3.310 1.697 0.0963
Hopeless 4.390 57.488 <0.0001
Guilty 3.888 3.208 0.0366
Headache 2.342 0.003 0.4765
Anxiety 4.176 242.999 <0.0001
Aches 3.006 8.185 0.0021
Irritability 4.112 239.628 <0.0001
Mood Swings 4.447 242.065 <0.0001
Weight Gain 3.429 162.829 <0.0001
Food Cravings 3.294 144.294 <0.0001
No Interest in Activities 4.188 17.345 <0.0001
Cramps 2.137 0.163 0.3431
Depression 4.209 66.623 <0.0001
Breast Tenderness 2.727 48.008 <0.0001
Insomnia 3.212 6.210 0.0064
Difficulty Concentrating 4.132 12.945 0.0002
Although most items in the full model were highly significant according to the
corrected p-value, several items were candidates for elimination based on the Score
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test. In particular, lack of coordination (T = 1.697, p = 0.0963), headaches (T =
0.003, p = 0.4765), and cramps (T = 0.163, p = 0.3431) were all non-significant
in the full model. The most significant items in the full model were anxiety (T =
242.9, p <0.0001), irritability (T = 239.6, p <0.0001), and mood swings (T = 242.1,
p <0.0001).
2.5 Simulations
Simulations were performed to assess the behavior of the Score test of the MIMIC
model in comparison to the Wald test given by PROC CALIS under several con-
ditions. A smaller set of items was chosen for simulations due to computing time.
This set of items was chosen to represent three highly correlated and significant
mood items and one “junk” item that was a candidate for elimination. The MIMIC
model also included the “gold standard” diagnosis measure for PMS. Simulation 1
investigated the performance of the Score test under the null hypothesis, in which
the “junk” item truly contributed no information to the model. In this simulation,
three multivariate normal random variables were generated using the observed mo-
ments of anxiety, irritability, and mood swings from the original sample. Simulated
data were generated such that there was a one standard deviation shift in the mean
of the latent variable between subjects with PMS and no PMS to reflect the asso-
ciation between the correlated items and the gold standard. An additional normal
random variable was generated with the mean and standard deviation of cramps
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in the original sample. This item was uncorrelated with the simulated mood items
and was not associated with the gold standard. In each simulation, 1000 bootstrap
samples were taken from a simulated dataset of N = 684. Type I error of the Score
and Wald tests for the simulated “junk” item was calculated for various levels of
correlation among the simulated mood items.
Table 2.4: Simulation 1 results. Data generated under null hypothesis.
Score Test Wald Test
ρMood Type I Error Rate Type I Error Rate
0.8 0.011 0.062
0.6 0.021 0.077
0.5 0.061 0.058
0.4 0.095 0.075
0.3 0.101 0.079
0.15 0.187 0.110
0.075 0.241 0.091
Simulation 2 investigated the performance of the Score and Wald tests under the
alternative hypothesis, where the “junk” item was truly correlated with the latent
variable and was associated with the “gold standard.” For this simulation four
multivariate normal random variables were generated with the means and standard
deviations of the items from the original dataset. Each of the simulated items was
associated with the gold standard such that there was a 0.5 standard deviation
increase in the mean of the latent variable for those with severe PMS. Similar
to Simulation 1, for each simulation, 1000 bootstrap samples were taken from the
simulated dataset and MIMIC models were fit to each. Power of the Score and Wald
tests was calculated for each simulation. Correlations among the simulated mood
items and between the junk item and the mood items were varied for Simulation 2.
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Table 2.5: Simulation 2 results. Data generated under the alternative hypothesis.
ρMood ρJunk Score Test Wald Test
Power Power
0.6 0.60 1.000 1.000
0.6 0.30 1.000 1.000
0.6 0.15 1.000 1.000
0.6 0.10 1.000 1.000
0.6 0.05 0.727 0.588
0.6 0.00 0.855 0.763
0.3 0.60 1.000 1.000
0.3 0.30 1.000 1.000
0.3 0.15 1.000 1.000
0.3 0.10 1.000 1.000
0.3 0.05 1.000 1.000
0.3 0.00 0.853 0.844
Table 2.4 displays results from Simulation 1, where the “junk” item was not
correlated with the mood items or associated with the gold standard. When the
correlation between the mood items was set relatively high, at ρMood = 0.6 or
above, Type I error rate of the Score test was much better than that of the Wald
test. For example, at ρMood = 0.6, the Type I error for the Score test was only 0.021
as compared to 0.077 for the Wald test. As the correlation among mood items
decreased, the Type I error for the Score test increased significantly. For example,
when ρMood = 0.3, the Type I error for the Score test was 0.101 as compared to 0.079
for the Wald test. The Type I error of the Wald test was always larger than the
nominal level and increased as the correlation among the items decreased. However,
Score test Type I error performance was influenced more by the correlation among
the other items than was the Wald test.
Table 2.5 presents results from Simulation 2, where the “junk” item was corre-
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lated with the mood items and associated with the “gold standard.” Power remained
high under most conditions. For both ρMood = 0.6 and ρMood = 0.3, power did not
drop substantially until ρJunk reached below 0.1. For ρMood = 0.6 and ρJunk = 0.05,
power for the Score test was 0.727 and power for the Wald test was 0.588. For
ρMood = 0.3 and ρJunk = 0.0, power for the Score test was 0.853 and power for the
Wald test was 0.844, illustrating that the Score test was more powerful than the
Wald test. The power of both tests remained high unless ρJunk was quite small.
Also notable is that power for the Score test was consistently higher than power
for the Wald test under the condition that ρJunk was small. Finally, it seemed that
power was affected not only by small values of ρJunk, but also by the magnitude of
the difference between ρMood and ρJunk. This was evidenced in that for ρMood = 0.6
and ρJunk = 0.05, power dropped below 1.0. However, for ρMood = 0.3 and ρJunk =
0.05, power remained at 1.0. In sum, both the Score and the Wald test were robust
to changes in correlations of the mood and junk items.
2.6 Discussion
The objective of this chapter was to evaluate items under consideration for inclusion
in a scale while simultaneously comparing the scale under development to a “gold
standard” measure. The results of our evaluation of the 17 DSR items showed that
the MIMIC model can be useful to inform item reduction. Three of the DSR items
in the full MIMIC model were identified as potential items for removal according
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to the Score test. Removing these items could help to create a stronger core set of
symptoms for PMS diagnosis.
It is not entirely surprising that headaches, lack of coordination, and cramps
were nonsignificant in the full model. While premenstrual headaches exist, they are
not limited to the premenstrual period, and this could be why the symptom is not
able to discriminate between PMS and non PMS groups. Further, poor coordination
is considered to an indicator of major depression as well as a potential symptom of
PMS. Cramps are diagnostically an indication of dysmennorhea rather than PMS.
Thus, it is reasonable to believe that poor coordination and cramps are not the best
indicators of PMS for these data but instead other related conditions.
Standard psychometric measures did not provide a clear picture of which items
were most important. Item-total correlations displayed a range of values and allowed
ranking of items in terms of importance to the scale, but none of the item-total
correlations fell below the standard guideline of 0.2. Cronbach’s alpha values were
all above the suggested guideline of 0.9, which suggested general item redundancy
but did not provide any indication of which particular items were redundant. The
MIMIC model provided clearer results as well as an objective test of the significance
of the items. Including the validation component into the model indicated that
several items could be considered for removal.
In addition to using the MIMIC model generally, the use of the Score test derived
in this paper for the MIMIC model is advocated for a number of reasons. Under the
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constraint that factor loadings must be non-negative, the statistical test of a factor
loading is a test of a variance component on the boundary of the parameter space.
As a result, it is important to take into account that the Score test statistic no longer
follows the traditional chi-square distribution and that the conventional Wald test is
invalid. Instead, the test statistic follows a mixture of chi-square distributions, and
the use of the modified Score test is more appropriate because it uses the correct
chi-square distribution for this situation. Furthermore, simulations showed that
when the null hypothesis was true the Score test performed better than the Wald
test in the presence of a set of moderately correlated items and a true uncorrelated
“junk” item. When the alternative hypothesis was true and the suspected junk
item was actually a meaningful part of the model, although the Score and Wald
tests generally yielded high power, the Score test performed better in proximity to
the null hypothesis (i.e. when the correlation, ρJunk, was very small). The Score
test presented here provides a preferable alternative to the Wald test for performing
item reduction.
Item reduction and validation are common procedures for scale development.
Rather than performing these processes separately, it has been demonstrated that
it is advantageous to combine them into a single latent variable model. This model
eliminates the potential bias induced by using separate item selection and validation
procedures with better precision. While latent variable models such as the MIMIC
model are more complex than simple factor analysis or psychometric measures such
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as Cronbach’s alpha, there is software available to estimate these types of latent
variable models. An impartial method of analyzing items that is justifiable from
a statistical perspective could add credibility to the usually subjective process of
item selection, and adding a validation metric to the same model allows for the
estimation of the relationship between the items and a “gold standard” measure.
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Chapter 3
Application of Joint Latent
Variable Model for Item
Reduction and Validation for
Ordered Categorical Scale Items
3.1 Introduction
As shown in the previous chapter, joint latent variable methods such as the MIMIC
model for continuous observed outcomes can be useful in combining item reduc-
tion and validation. Fortunately, extensions to classic latent variable models for
continuous outcomes are available for other types of responses as well. Symptom
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scales often involve Likert scale data that can be modeled as ordered categorical.
In this chapter we focus on methods for categorical observed outcomes in which
we assume that all observed responses originate from a continuous latent variable.
Several extensions to classic latent variable models are highlighted below and an
ordered categorical extension to the MIMIC model is presented with an illustration
from the PAL clinical trial.
An extension of unidimensional factor analysis for dichotomous or ordered cate-
gorical items, item response theory (IRT) is widely used in educational testing and
is becoming more prevalent in health measurement (Rasch, 1960). IRT models use
a latent variable framework to explain the probability of “correctly” answering test
items. Similar to factor loadings for continuous outcome factor analysis, discrimi-
nation parameters in IRT models are often used as metrics for item reduction.
Multi-trait multi-method (MTMM) models offer an alternative approach to eval-
uating measurement error (Campbell and Fiske, 1959). The most basic method, the
MTMM matrix, consists of correlations of several concepts or traits measured by
each of several methods. This correlation matrix provides estimates of reliability
for each trait and method pair as well as estimates of validity for different mea-
sures of the same trait. While the MTMM matrix allows for useful estimates of
reliability and validity, limitations of the MTMM matrix include the lack of rig-
orous statistical tests associated with correlation coefficients and the inability of
the MTMM matrix to separate method variance from random error. ANOVA and
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latent variable models like confirmatory factor analysis are proposed to account for
these issues. ANOVA partitions variance into groups defined by person, method,
and trait and provides a global estimate of each type of variance (Guilford, 1954).
Repeated measures are needed to estimate trait-method interactions. The confirma-
tory factor analysis model provides estimates of correlation among observed traits
and methods through factor loadings (Werts and Linn, 1970). The model contains
several components: a trait component, a method component and a random error
component. Overall, MTMM models provide an additional approach to assessing
validity and can be useful in evaluating a “gold standard.”
As in the previous chapter, to explore the efficiency of performing item selection
and validation in one model, we employed a MIMIC model (Joreskog and Gold-
berger, 1975). An extension to the MIMIC model for categorical items assumes
that ordinal items originate from underlying unobserved continuous, normally dis-
tributed items. The model relates observed items with underlying unobserved items
through a series of threshold relationships (Muthe´n, 1984a).
Data from the PAL clinical trial was considered as a motivating example (Schmitz
et al., 2009, 2010). The primary aim was to identify important and clinically rele-
vant symptoms from ordered categorical items in a scale and to demonstrate that
this set of symptoms had a strong association with the “gold standard” arm vol-
ume difference. The remainder of the chapter is outlined as follows. Section 3.2
illustrates the MIMIC model and its formulation for Likert scale data, Section 3.3
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describes the PAL sample, Section 3.4 presents results of the example, and in Sec-
tion 3.5 I draw some conclusions.
3.2 Methods
Similar to Chapter 2, the MIMIC model was formulated such that the single latent
variable is interpretable as a continuous measure of lymphedema severity. As a
means of comparison, lymphedema symptoms were also analyzed using standard
psychometric techniques such as item-total correlation and Cronbach’s alpha. The
relationship between individual symptoms and the “gold standard” diagnostic mea-
sure of lymphedema was assessed with cumulative probit models.
3.2.1 MIMIC Model Specification
Consider a sample of n individuals from whom a set of m ordered categorical Lik-
ert scale outcome measurements (items), yi1, ..., yim, and one continuous validation
measurement (“gold standard”), zi, are taken. The ordinal items are assumed to
have originated from continuous, normally distributed items y∗i1, ..., y
∗
im. For sub-
ject i = 1, ..., n and outcome measurements j = 1, ..,m, the measurement model is
specified as
y∗i(m×1) = µ(m×1) + λ(m×1)bi(1×1) + i(m×1) (3.2.1)
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where µ is a vector of means, λ is a vector of factor loading parameters, bi is the
latent variable (lymphedema severity), and i is a vector of specific variances. In
the classical MIMIC model y∗i is assumed to be directly observed, but here it is
unobserved. Instead, the relationship between unobserved y∗i and observed yi is
specified by
yi = C − 1 if τC−1 < y∗i
= C − 2 if τC−2 < y∗i ≤ τC−1
=
...
= 1 if τ1 < y
∗
i ≤ τ2
= 0 if y∗i ≤ τ1
where the τ ’s are threshold parameters defining category intervals on y∗i . The
structural model with a single “gold standard” is specified as
bi(1×1) = β(1×1)zi(1×1) + δi(1×1) (3.2.2)
where β is the regression coefficient measuring the association between the latent
variable and the “gold standard.” The random variable δi is an error term for
the latent variable, and we assumed V ar(δi) = 1, allowing the latent variable to
be interpreted on a standardized scale. Estimation of the model was performed
using the mean and variance adjusted weighted least squares estimator and Delta
parameterization in Mplus Version 6.1. Example code for the ordinal version of the
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MIMIC model is provided in Appendix B.
3.3 Application to Physical Activity and Lym-
phedema Clinical Trial
A prominent fear for many breast cancer survivors, lymphedema is a debilitating
chronic disease that results from surgical excision of lymph nodes as part of breast
cancer treatment. In addition to swelling, lymphedema can cause skin changes,
reduction of limb function, and loss of sensation as well as depression, decreased
quality of life, decreased physical self-esteem and other physical and psychological
morbidities (Ahmed et al., 2008; Cormier et al., 2009; Shih et al., 2009).
Until recently, women at risk for or diagnosed with lymphedema have been en-
couraged to limit physical activity, even such mundane tasks as lifting grocery bags.
This guideline has the effect of inhibiting everyday activities and may even slow
physical recovery from cancer. However, results of the PAL trial contradicted these
guidelines, showing that a progressive weight-training program was safe for breast
cancer survivors. Among women diagnosed with lymphedema, the trial showed that
a weight-training intervention was not only safe in that it did not significantly affect
lymphedema severity, but it also was shown to effectively reduce the number and
severity of arm and hand symptoms and the incidence of lymphedema exacerbations
(Schmitz et al., 2009). A subsequent follow-up study indicated that in breast cancer
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survivors who were at risk for lymphedema but who had not yet been diagnosed, a
much larger group, the same weight-training intervention was not associated with
an increased incidence of lymphedema (Schmitz et al., 2010). That weight-lifting
was shown to be safe for both women at risk for lymphedema and women already
diagnosed with lymphedema was revolutionary as great benefits such as increased
muscle strength, decreased weight gain, and increased quality of life have been
shown to result from increased physical activity (Schmitz et al., 2010).
Incidence of lymphedema in the literature varies dramatically with estimates
between 6% to 70% (Schmitz et al., 2009). One factor attributed to the differ-
ence is the criteria used for diagnosis of lymphedema. Several diagnostic measures
include: water displacement volumetry, extracellular water in the arm measured
by multi-frequency bioelectrical impedance analysis, serial circumference measure-
ments and truncated cone volumetry. Initial evidence indicates that self-reported
lymphedema symptoms can be as useful as objective diagnostic measures in dis-
criminating women with lymphedema from those without (Norman et al., 2001).
Self-report of symptoms could be a useful measure in diagnosing lymphedema be-
cause patients are more aware of acute changes in swelling, skin tone, and function.
Furthermore, it is argued that patient pain or distress should be incorporated in
the diagnosis of lymphedema and that swelling alone is not sufficient for diagno-
sis. We explored the relationship among symptoms and a limb volume difference
“gold standard” measure to determine the utility of this information in summarizing
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lymphedema severity.
Outcome measures included self-reported lymphedema symptoms and an objec-
tive “gold standard” measure of lymphedema severity. The self-reported symptoms
were measured using the validated Norman Lymphedema Survey (Norman et al.,
2001). The severity of 13 symptoms was assessed: rings too tight, watch too tight,
bracelets too tight, clothing too tight, puffiness, knuckles not visible, veins not vis-
ible, skin feels leathery, arm feels tired, pain, pitting, swelling after exercise, and
difficulty writing. Symptoms were measured on a 5-point Likert scale with responses
ranging from 0 (no symptom) to 4 (very severe). Water displacement volumetry
was chosen as the “gold standard” and was measured as the percent difference in
volume between the lymphedema-affected and unaffected arms.
EFA models for ordered categorical outcomes revealed three distinct factors from
the Norman Lymphedema Survey items. One symptom, swelling after exercise, did
not load strongly on any factor. This symptom was chosen as a “junk” item, po-
tentially eligible for removal from the scale. The factor representing tissue, swelling
and function was chosen for further investigation. This factor included the fol-
lowing symptoms: clothing too tight, puffiness, skin feels leathery, arm feels tired,
pain, and difficulty writing. In the MIMIC model, Norman lymphedema symptoms
served as observed indicators and volume difference served as the observed cause.
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3.4 Results
Data for the example came from a subset of the PAL trial. The sample comprised
N = 141 women diagnosed with lymphedema at baseline. The average volume
difference, defined as the percent difference in arm volume between affected and
unaffected arms, for the sample was 16.11 percent [95% C.I. (13.59, 18.65)]. Figure
3.1 illustrates the association between individual symptom response categories and
average percent volume difference. For clothing too tight, puffiness, skin feels leath-
ery, and arm feels tired, there was a general increase in mean volume difference
with increasing levels of symptom severity. Because of the small sample sizes in
response category of very severe for pain and difficulty writing (n = 2 and n = 3,
respectively), responses severe and very severe were combined. There did not ap-
pear to be a trend in the association between mean volume difference and symptom
severity for pain, difficulty writing, or swelling after exercise.
Polychoric correlations among the symptoms are presented in Table 3.1. Cor-
relations among the items in the swelling/function factor were generally moderate
to strong, ranging from ρPain, Clothing = 0.222 to ρPuffiness, Clothing = 0.742. Corre-
lations among the junk item and other items were much smaller, ranging from
ρPuffiness, Swelling = −0.002 to ρWriting,Exercise = 0.220. These correlations provided ini-
tial evidence that swelling after exercise could be a candidate for removal because
it did not correlate highly with the other items.
Standard psychometric techniques also identified swelling after exercise as po-
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Figure 3.1: Mean volume difference plots with error bars for Norman Lymphedema
Survey items.
tential “junk” (see Table 3.2). Item-total correlations when all items were included
in the scale ranged from ρ = 0.111 for swelling after exercise to ρ = 0.666 for arm
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Table 3.1: Polychoric correlations of Norman Lymphedema Survey items.
Clothing Puffiness Skin Feels Arm Feels Pain Difficulty Swelling
too tight Leathery Tired Writing
Clothing Too Tight 1.0000
Puffiness 0.7422 1.0000
Skin Feels Leathery 0.5219 0.5814 1.0000
Arm Feels Tired 0.4514 0.6718 0.5426 1.0000
Pain 0.2217 0.4231 0.3323 0.5455 1.0000
Difficulty Writing 0.2408 0.4141 0.2257 0.5687 0.3858 1.0000
Swelling 0.0322 -0.0017 0.1966 0.2169 -0.0112 0.2197 1.0000
Table 3.2: Standard psychometric measures of Norman Lymphedema Survey items.
Symptom Item-total Correlation Alpha
Clothing Too Tight 0.474 0.687
Puffiness 0.636 0.647
Skin Feels Leathery 0.495 0.682
Arm Feels Tired 0.666 0.639
Pain 0.382 0.709
Difficulty Writing 0.358 0.715
Swelling After Exercise 0.111 0.769
feels tired. According to the ρ = 0.2 guideline (Streiner and Norman, 1994), swelling
after exercise could potentially be considered for removal. The overall Cronbach’s
alpha assuming all seven items in the scale was α = 0.727, indicating that the
removal of swelling after exercise is unwarranted.
Results from univariate cumulative probit models are featured in Table 3.3.
According to these models, there was a statistically significant relationship between
volume difference and increasing item severity for clothing too tight and puffiness
(p < 0.001 for both). In both of these models, the cumulative probability starting
at the severe end of the scale increased with higher levels of volume difference
(βClothing too tight = 0.030, S.E. = 0.006, βPuffiness = 0.029, S.E. = 0.007). In other
words, symptom severity for clothing too tight and puffiness tended to be more
intense as volume difference increased. All other items identified in the exploratory
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model as well as the potential “junk” item were not significantly associated with
volume difference when considered individually.
When symptoms were considered jointly, factor loadings from the ordinal MIMIC
model indicated a strong relationship among the candidate items and the latent
measure of lymphedema severity (see Table 3.4). For these items identified by EFA,
factor loadings exceeded 0.5 and ranged from λPain = 0.512 to λPuffiness = 0.906. All
factor loadings for candidate items were statistically significant (p < 0.001). The
factor loading for swelling after exercise was small (λSwelling = 0.145) and the test
for the factor loading was not statistically significant (p = 0.132), indicating that
this item did not contribute to the underlying measure of lymphedema severity.
The coefficient for the regression of the latent lymphedema severity on volume dif-
ference was β = 0.020 and was statistically significant (p = 0.001). This represents
a global test of the significance of the relationship between volume difference and
all items in the MIMIC model. The regression coefficient can be interpreted as
follows: every 1% change in volume difference corresponded to a β = 0.020 change
in latent lymphedema severity on the standard normal scale. In other words, a clin-
ically meaningful change in volume difference of 5% would correspond to a change
of β = 0.10, an effect size of 0.1 standard deviation units in the latent measure of
lymphedema severity.
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Table 3.3: Univariate cumulative probit models.
Symptom Estimate SE P
Clothing too tight
α1 0.356 0.150 0.017
α2 0.723 0.153 <0.001
α3 1.746 0.199 <0.001
α4 2.797 0.396 <0.001
β 0.030 0.006 <0.001
Puffiness
α1 -0.503 0.156 0.001
α2 0.106 0.146 0.467
α3 1.260 0.176 <0.001
α4 2.363 0.259 <0.001
β 0.029 0.007 <0.001
Skin feels leathery
α1 0.431 0.157 0.006
α2 0.796 0.169 <0.001
α3 1.452 0.206 <0.001
α4 1.940 0.255 <0.001
β 0.007 0.006 0.260
Arm feels tired
α1 -0.394 0.151 0.009
α2 -0.032 0.146 0.829
α3 0.963 0.159 <0.001
α4 1.771 0.211 <0.001
β 0.007 0.006 0.243
Pain
α1 0.138 0.148 0.352
α2 0.399 0.151 0.008
α3 1.140 0.170 <0.001
α4 2.161 0.286 <0.001
β -0.002 0.006 0.751
Difficulty writing
α1 0.905 0.178 <0.001
α2 1.014 0.180 <0.001
α3 1.503 0.206 <0.001
α4 2.227 0.320 <0.001
β 0.002 0.008 0.771
Swelling after exercise
α1 0.632 0.175 <0.001
α2 0.847 0.192 <0.001
α3 1.497 0.219 <0.001
α4 NA NA NA
β -0.002 0.008 0.842
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Table 3.4: Ordered categorical MIMIC model applied to PAL data.
Symptom Estimate SE P
Factor Loadings
Clothing too tight 0.709 0.051 <0.001
Puffiness 0.906 0.038 <0.001
Skin feels leathery 0.631 0.057 <0.001
Arm feels tired 0.779 0.038 <0.001
Pain 0.512 0.069 <0.001
Difficulty writing 0.526 0.075 <0.001
Swelling after exercise 0.145 0.096 0.132
Regression Coefficient
β 0.020 0.006 0.001
Thresholds
Clothing too tight
α1 0.356 0.150 0.017
α2 0.723 0.153 <0.001
α3 1.746 0.199 <0.001
α4 2.798 0.396 <0.001
Puffiness
α1 -0.503 0.156 0.001
α2 0.106 0.146 0.467
α3 1.260 0.176 <0.001
α4 2.363 0.259 <0.001
Skin feels leathery
α1 0.431 0.157 0.006
α2 0.796 0.169 <0.001
α3 1.452 0.206 <0.001
α4 1.940 0.255 <0.001
Arm feels tired
α1 -0.394 0.151 0.009
α2 -0.032 0.146 0.829
α3 0.963 0.159 <0.001
α4 1.771 0.211 <0.001
Pain
α1 0.138 0.148 0.352
α2 0.399 0.151 0.008
α3 1.140 0.170 <0.001
α4 2.161 0.286 <0.001
Difficulty writing
α1 0.905 0.178 <0.001
α2 1.014 0.180 <0.001
α3 1.503 0.206 <0.001
α4 2.228 0.320 <0.001
Swelling after exercise
α1 0.632 0.175 <0.001
α2 0.847 0.192 <0.001
α3 1.497 0.219 <0.001
α4 NA NA NA
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3.5 Discussion
In terms of the motivating example, standard psychometric techniques, univariate
models, and the MIMIC model provided somewhat conflicting results. Item-total
correlations identified swelling after exercise as a potential junk item. While psycho-
metric techniques took into account the relationship among symptoms, they did not
take into account the relationship between items and “gold standard” volume differ-
ence. Cumulative probit models revealed a significant relationship between volume
difference and only two of the items: clothing too tight and puffiness. These mod-
els were useful for describing the relationship between volume difference and item
severity scores in the univariate setting but did not consider the correlation among
the items and how all the items together are associated with volume difference. The
MIMIC model showed that six of the seven items in the model were significant com-
ponents of latent lymphedema severity. The MIMIC model is advocated because
it takes into account the correlation among the items as well as the relationship
between the latent measure of severity and the “gold standard.” Unlike the stan-
dard psychometric techniques, which assume an underlying normal distribution of
the items, the categorical formulation of the MIMIC model is an appropriate choice
for ordinal data. The results of our evaluation of the Norman symptoms showed
that the MIMIC model can be useful to inform item reduction. The MIMIC model
suggested that the potential junk item was not statistically significant and could be
considered for removal. There are several directions for future work based on the
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methods investigated in this chapter. Of particular interest is the influence of scale
item distributions on MIMIC model estimates. I noticed that there was a significant
proportion of non-response for many of the Norman Lymphedema Survey items. In
Chapter 4 I investigate the effects of skewed item distributions and propose a new
model to account for significant symptom non-response.
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Chapter 4
A Joint Latent Variable Model for
Item Reduction and Validation in
the Presence of a Preponderance
of Zeros
4.1 Introduction
In this chapter I propose an extension to the ordered categorical MIMIC model
presented in Chapter 3. In the case of highly skewed item distributions it is possible
that estimates from a standard MIMIC model are not entirely accurate, and in
the motivating example the Norman Lymphedema Survey scale items exhibited a
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preponderance of zeros. The methodological objectives in this chapter are two-
fold: First, simultaneously and efficiently perform item reduction and validation
using a joint latent variable model, and second, determine a method to account
for the excess zeros in item distributions. In this chapter I propose a multivariate
zero-inflated proportional odds (MZIPO) model, a joint latent variable model that
accomplishes both tasks simultaneously. The MZIPO model yields more accurate
estimates both of the relationship between individual symptoms and the latent
variable and the relationship between the latent variable and the gold standard
diagnostic measure than if a standard MIMIC model were used.
The proposed MZIPO model can be thought of as an extension of several sta-
tistical models. This section highlights several models that motivate the MZIPO
model. Several previous latent variable models formulated for ordered categorical
data establish a foundation for the MZIPO model. As discussed in Jo´reskog and
Moustaki (2000), latent variable models for ordered categorical items are generally
framed either from an underlying response function approach where it is assumed
that an observed ordered categorical item is a manifestation of an underlying con-
tinuous latent variable (Muthe´n, 1984b; Jo´reskog, 1994), or a response function
approach, which was originally developed in item response theory (IRT) as de-
scribed by the graded response model (Samejima, 1970). Extensions to the graded
response model accommodate multiple latent variables and a variety of link func-
tions. Moustaki (2000) presents a general class of latent variable models for ordinal
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items in a regression framework similar to McCullagh (1980).
Other extensions allow for mixed observed outcome types. Sammel et al. (1997)
propose a latent variable model for mixed discrete and continuous outcome types
that also allows for the inclusion of covariates. This model accommodates any type
of observed outcome that can be framed as a generalized linear model. The estima-
tion method presented in Sammel et al. motivated the EM estimation procedure
used in the MZIPO model, which is described in Section 4.3.
In addition to models for mixed observed outcome types, a general class of latent
variable models allows for mixed latent variable types. Proposed by Muthe´n (2008),
latent variable hybrid models contain discrete and continuous latent variables and
accommodate cross-sectional or longitudinal data. The cross-sectional formulation
of these models, also known as factor mixture models (FMMs), combines the classic
factor analysis model and the classic latent class model to cluster items into a
smaller set of dimensions and subjects into unobserved subpopulations. The main
objective of FMMs is to determine structural relations between latent and observed
variables in the presence of unobserved population heterogeneity. If subjects could
be classified into any number of observed groups then multiple group latent variable
methods could be used. However, when population heterogeneity is unobserved,
latent classes can be used to infer subpopulations of interest. Additionally, FMMs
allow for the inclusion of covariates, which can help to explain the unobserved
heterogeneity present in the data. The MZIPO model fits in the framework of
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FMMs, but the model is distinct because the latent classes have a slightly different
form than FMMs. In the MZIPO approach it is assumed that one of the classes
has a degenerate distribution. In the motivating example it was of interest to
determine, among subjects who did not experience symptoms at baseline, who was
truly susceptible to experiencing lymphedema incidence or exacerbations.
Statistical models that accommodate both continuous and discrete latent vari-
ables have been described elsewhere (Arminger et al., 1999; Dolan and van der
Maas, 1998; Yung, 1997) but until recently have lacked popularity in psychometrics
and biomedical research. These models are extremely useful for our application
because they will allow us to distinguish between groups of patients who are truly
at a greater risk for lymphedema from those whose symptoms do not indicate a
substantial risk. Factor mixture models to accommodate sample heterogeneity for
quantitatively measured outcomes are described generally in Muthe´n and Shedden
(1999) and Lubke and Muthe´n (2005). Several other articles have assessed model
performance of the factor mixture model under various conditions (Lubke and Neale
(2006), Lubke and Muthe´n (2007)). Lubke and Neale (2008) builds on Lubke and
Neale (2006) by extending the model to deal with binary and ordinal outcomes. In
general, FMMs will be useful in comparing the symptom profiles of those at risk to
an objective “gold standard” measure of lymphedema severity.
In addition to FMMs, one particular statistical model served as motivation for
the MZIPO model. In the motivating example, I utilize the latent class to account
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for zero inflation in the symptom battery, thus extending the work of Kelley and
Anderson (2008) who addressed this issue in a univariate setting. Their model, a
univariate zero-inflated proportional odds (ZIPO) model, is a mixture model that
incorporates the probability of non-response into an ordinal regression model. Simi-
lar to the zero-inflated Poisson model, the ZIPO model accounts for non-responders
using a mixture model approach but is intended for ordered categorical observed
outcomes. The ZIPO model is particularly useful because it allows for the simultane-
ous modeling of symptom frequency and severity in the presence of a preponderance
of zeros.
The rationale of the ZIPO model is that the mixture distributions come from a
population that can be divided into two unobserved states. The unsusceptible state
includes those subjects who experience “true” symptom non-response. On the other
hand, the susceptible state includes subjects for whom a particular symptom may
not present at the time of data collection but who is still susceptible to experiencing
the symptom at a different time or under different conditions. As a result, the
conditional distribution for the ordinal regression may still contain some observed
zeros.
Building on the papers cited above, the MZIPO model fits into the general class
of factor mixture models as it combines a classic factor analysis model and latent
class model components. It is unique from the traditional factor mixture model,
however, in that the latent class component is used to account for zero-inflation
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in the data, so that one of the mixture distributions is assumed to be degenerate.
The MZIPO model can be thought of as an extension to the ZIPO model in several
ways. First, we are extending the ZIPO model to accommodate multiple observed
ordinal outcomes. This extension allows for the evaluation of an entire battery of
symptom items simultaneously rather than each item individually. Next, in order
to model the multivariate ordinal outcomes the model also includes a continuous
latent variable. Including the continuous latent variable provides a single weighted
summary measure of the multivariate outcomes, or latent factor score, for each
individual. The MZIPO model incorporates useful features of previously proposed
latent variable models to accomplish the objectives set for the motivating example.
The rest of the chapter is outlined as follows: Section 4.2 specifies the MZIPO
model, Section 4.3 outlines estimation via the EM algorithm, Section 4.4 describes
the motivating example, Section 4.5 presents results of the application of the MZIPO
model, and finally conclusions are given in Section 4.6.
4.2 Model Specification
Let yij be an ordered categorical measure for subject i = 1, ..., n on item j = 1, ...,m
where each item contains k = 1, ..., Kj response categories.
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4.2.1 Measurement Model
The measurement model is an ordered categorical factor analysis model assuming
a proportional odds structure for observed ordinal items as described by Jo´reskog
and Moustaki (2000). The model measures the relationship between individual
scale items and the continuous latent disease severity measure. This model can
be thought of as a latent variable formulation of a multivariate generalized linear
model. Similar models with a variety of link functions can be found in Moustaki
(2000). For a model with a single continuous latent variable and a logit link, the
measurement model is specified as
ln
[
γ
(j)
k (b)
1− γ(j)k (b)
]
= α
(j)
k − βjbi
where γ
(j)
k (b) = Pr(yij ≤ k) = pi(j)1 (b) + ... + pi(j)k (b) is the probability of a response
in category k or lower on variable j. It follows that
γ
(j)
k (b) =
exp
[
α
(j)
k − βjbi
]
1 + exp
[
α
(j)
k − βjbi
] = Ψ [α(j)k − βjbi]
where Ψ(.) is the distribution function of the logistic distribution. Therefore, the
conditional distribution of (yij | bi) is given by
f(yij | bi) =
Kj∏
k=0
pi
(j)
k (bi)
I[yij=k] =
Kj∏
k=0
(
Ψ
[
α
(j)
k − βjbi
]
−Ψ
[
α
(j)
k−1 − βjbi
])I[yij=k]
.
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I[yij = k] is an indicator function that equals 1 if yij = k and 0 otherwise.
4.2.2 Structural Model
The structural model measures the relationship between the continuous measure of
latent disease severity and the “gold standard” diagnostic measure. The model is
a simple linear regression model
bi = τTi + δi
where τ is the coefficient for the regression of the latent variable on the gold stan-
dard, Ti is the gold standard covariate measure, and δi is the error term for the
latent variable. The test of the regression coefficient in the model serves as an
indicator of criterion validity in that it measures the strength of the relationship
between the “gold standard” diagnostic measure and disease severity as measured
by the observed scale items. For purposes of identifiability it is assumed in this case
that Var(δi) = 1, although other constraints are possible (Muthe´n and Shedden,
1999).
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4.2.3 Latent Class Model
Define latent class ci as a categorical latent variable with two classes to represent
the susceptible and unsusceptible states such that
ci =

1, if yi is in the unsusceptible state
0, if yi is in the susceptible state.
Note that latent class membership is based on the entire vector of observed item
responses.
Observed Response and Latent Class Assignment
As described in the introduction to this chapter, it is assumed that the unobserved
unsusceptible state contains only “true” symptom non-response. Define observed
responders as those subjects who have a non-zero response to at least one of the
scale items. An observed non-responder is then defined as a subject who exhibits
a zero response to all scale items. An important element in the MZIPO model
is that the classification in the observed responder group means that a subject
will automatically be assigned to the susceptible state. The MZIPO model then
classifies all observed non-responders into either the unsusceptible or susceptible
state. A comparison of observed response and latent class assignment is presented
later.
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4.2.4 Complete Data Likelihood
For the purpose of model building the latent class assignment is treated as missing
data. Suppose it was possible to know which subjects came from the unsusceptible
state and which came from the multinomial distribution (susceptible state). Latent
class assignment could be defined as zi = 1 when the observed responses for subject
i (yi) came from the unsusceptible state and zi = 0 when the responses came from
the multinomial distribution. For parameter vector Θ = [α
(j)
k ,β, τ, p] a complete-
data likelihood could be constructed as
L =
n∏
i=1
f(yi, zi, bi | Θ) =
n∏
i=1
Pr(yi = 0, zi = 1)
zi Pr(yi = k, zi = 0, bi)
(1−zi).
Because the unsusceptible class includes only zero responses on all observed out-
comes,
Pr(yi = 0, zi = 1) = Pr(yi = 0 | zi = 1)Pr(zi = 1)
= p.
Note that Pr(zi = 0) = 1 − p,Pr(zi = 1) = p because the prevalence of the
unsusceptible and susceptible states is of interest. In other formulations of factor
mixture models and the ZIPO model, it is possible to allow for covariates to explain
the probability of latent class membership.
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An important assumption in the MZIPO model is that the latent class and the
continuous latent variable are independent of one another, i.e. bi ⊥⊥ zi . This
assumption allows for the separation of components in the model likelihood and
facilitates estimation of the model.
For subjects in the susceptible state,
Pr(yi = k, zi = 0, bi) = Pr(yi = k | zi = 0, bi) Pr(zi = 0 | bi)f(bi)
= Pr(yi = k | zi = 0, bi) Pr(zi = 0)f(bi)
= Pr(yi = k | zi = 0, bi)(1− p)f(bi),
where
Pr(yi = k | zi = 0, bi)
=
M∏
j=1
Kj∏
k=0
Pr(yij = k | zi = 0, bi)I[yij=k]
=
M∏
j=1
Kj∏
k=0
[γ
(j)
k (b)− γ(j)k−1(b)]I[yij=k]
=
M∏
j=1
Kj−1∏
k=0
[
Ψ
[
α
(j)
k − βjbi
]−Ψ[α(j)k−1 − βjbi]]I[yij=k][1−Ψ[α(j)K−1 − βjbi]]I[yij=K].
The final element of the complete data likelihood arises from the structural
model in which we assume the continuous latent variable to be normally distributed
f(bi) =
1√
2pi
e
−(bi−τTi)2
2
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Given the components defined above, the log-likelihood is given by
` = lnL =
n∑
i=1
zi ln p+ (1− zi) ln(1− p)
+
n∑
i=1
(1− zi)
M∑
j=1
[
K−1∑
k=0
I[yij = k] ln
[
Ψ
[
α
(j)
k − βjbi
]−Ψ[α(j)k−1 − βjbi]]
+ I[yij = K] ln
[
1−Ψ[α(j)K−1 − βjbi]]
]
+
n∑
i=1
(1− zi)
[
ln
1√
2pi
− 1
2
(bi − τTi)2
]
which, for the purpose of estimation, can be separated into three distinct portions
with parameters for the latent class, the measurement model, and the structural
model.
4.3 Model Estimation
The EM algorithm is a natural choice for estimation of the MZIPO model because
both types of latent variables can be considered missing data. Little and Rubin
(1987) demonstrated for data Y = (Yobs, Ymis), the EM algorithm proceeds by
first factoring the complete data log-likelihood into one piece for the marginal log-
likelihood of the observed data and one piece for the log-likelihood of the missing
data conditional on the observed data
`(θ | Y ) = `(θ | Yobs, Ymis) = `(θ | Yobs) + ln f(Ymis | Yobs, θ).
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Solving for `(θ | Yobs) yields
`(θ | Yobs) = `(θ | Y )− ln f(Ymis | Yobs, θ). (4.3.1)
As in Little and Rubin, the expectation of both sides of Equation 4.3.1 with respect
to the distribution of missing data given observed data is given by
E`(θ | Yobs) = Q(θ | θ(t))−H(θ | θ(t))
for
Q(θ | θ(t)) =
∫ ∞
−∞
[`(θ | Yobs, Ymis)]f(Ymis | Yobs) dYmis.
In the MZIPO model, define Y obs = (yi) and Y mis = (zi, bi) for Θ = [α
(j)
k ,β, τ, p]
so that
Q(Θ | Θ(t)) =
∫ ∞
−∞
[`(Θ | yi, Ti, zi, bi)]f(zi, bi | yi, Ti,Θ(t)) d(zi, bi)
where
`(Θ | yi, Ti, zi, bi) =
n∑
i=1
[
ln f(yi | zi, bi,Θ) + ln f(zi | Θ) + ln f(bi | Θ)
]
.
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In the M-step of the EM algorithm Q(Θ | Θ(t)) is maximized such that
∂
∂Θ
Q(Θ | Θ(t)) = 0.
Under certain regularity conditions (Little and Rubin, 1987, p. 136), met in our
example because the distribution of yi is multinomial, the order of integration and
differentiation can be reversed and the following equation can be solved
∂
∂Θ
Q(Θ | Θ(t)) =
∫ ∞
−∞
∂
∂Θ
[`(Θ | yi, Ti, zi, bi)]f(zi, bi | yi, Ti,Θ(t)) d(zi, bi) = 0.
Define h(bi, zi | yi) = f(zi, bi | yi,Θ(t)), the posterior distribution of the missing
data. Solving Q(Θ | Θ(t)) is equivalent to solving for the expected score function
S(θj) with respect to the posterior distribution of missing data given observed data
Eb,zSi(Θj) =
∫ ∞
−∞
∑
z
Si(Θj)h(b, z | yi) dbi. (4.3.2)
Because closed form solutions for Eb,zS(Θj) = 0 are not available, a Fisher scoring
algorithm is used to iteratively update estimates of Θj . Sammel et al. (1997)
and others showed that assuming conditional independence of the observed items
given the continuous latent variable, the parameter space can be separated into
components corresponding to each outcome. The expectation step, approximating
the integral Eb,zS(Θj), will also yield estimates of bi and zi by setting Eb,zS(Θj)=0,
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and solving for each parameter in the maximization step will give iterative estimates
of each parameter.
4.3.1 Expectation Step
Expectation of zi
A natural first step of the EM algorithm is the estimation of latent class membership.
An estimate of the expected value of zi given the posterior distribution is computed
as
Eh(b,z)(zi) =
∫ ∞
−∞
1∑
zi=0
zih(bi, zi | yi,θ) dbi,
=
∫∞
−∞
∑1
zi=0
zif(yi | bi, zi)f(bi | zi)f(zi) dbi∫∞
−∞
∑1
zi=0
f(yi | bi, zi)f(bi | zi)f(zi) dbi
. (4.3.3)
Considering the components separately, the numerator can be re-expressed as
∫ ∞
−∞
1∑
zi=0
zif(yi | bi, zi)f(bi | zi)f(zi) dbi
=
∫ ∞
−∞
(0)f(yi | bi, zi = 0)f(bi | zi = 0)f(zi = 0) dbi
+
∫ ∞
−∞
(1)f(yi | bi, zi = 1)f(bi | zi = 1)f(zi = 1) dbi
= p ∗ Pr(yi = 0 | zi = 1)
∫
b
f(bi | zi = 1) dbi
= p,
(4.3.4)
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and the denominator as
∫ ∞
−∞
1∑
zi=0
f(yi | bi, zi)f(bi | zi)f(zi) dbi
=
∫ ∞
−∞
f(yi | bi, zi = 0)f(bi | zi = 0)f(zi = 0) dbi
+
∫ ∞
−∞
f(yi | bi, zi = 1)f(bi | zi = 1)f(zi = 1) dbi
=
∫ ∞
−∞
(1− p)f(yi | bi, zi = 0)f(bi | zi = 0) dbi + p.
(4.3.5)
Putting Equation 4.3.4 and 4.3.5 together, zi can be estimated by
Eh(b,z)(zi) =
p
p+
∑T
t=1(1− p) wt exp(b2t ) f(yi | bt, zi = 0) f(bt | zi = 0)
. (4.3.6)
Note that Eh(b,z)(zi) = 0 for subjects with non-zero observed yi values because by
definition they cannot be part of the unsusceptible class. Furthermore, a dichoto-
mous estimate of Eh(b,z)(zi) for each subject is created at each iteration such that
(zˆi)
(s)
=1 if Eh(b,z)(zˆi) > 0.5 at iteration (s) and 0 otherwise.
Approximating Expectations using Gauss-Hermite Quadrature
Expectations of expected score functions and sufficient statistics necessary for the
estimation of the MZIPO model parameters cannot be directly evaluated because
the solutions are not available in closed form, so the Gauss-Hermite quadrature
method (Abramowitz and Stegun, 1964) was used. This method is often used to
solve complicated integrals involving the normal distribution. Though the continu-
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ous latent variable in the MZIPO model is normally distributed, the Gauss-Hermite
quadrature method will require a change of variables because the latent variable is
not distributed as standard normal. Many of the expectations required for estima-
tion contain the integral
∫ ∞
−∞
f(yi | bi, zi = 0)f(bi | zi = 0) dbi (4.3.7)
where f(bi) is given in Equation 4.2.1.
Using a change of variables such that
xi =
bi − τTi√
2
which implies
bi = τTi +
√
2xi,
Equation 4.3.7 can be written
∫ ∞
−∞
f(yi | bi = τTi +
√
2xi, zi = 0)
1√
2pi
exp
(−x2i ) dbidxi dxi
=
∫ ∞
−∞
f(yi | bi = τTi +
√
2xi, zi = 0)
1√
pi
exp(−x2i ) dxi
given dbi
dxi
=
√
2. This equation is in the form of integrals given in Liu and Pierce
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(1994) and can be approximated by
T∑
t=1
wt√
pi
f(yi | τˆTi +
√
2xt, zi = 0)
where xt is the t
th node of the Hermite polynomial and wt is the corresponding
weight. Gauss-Hermite approximation for Equation 4.3.6, the expected value of zi,
is given by
Eh(b,z)zi ≈ p
p+ (1− p)∑Tt=1 wt√pif(yi | τˆTi +√2xt, zi = 0)
and expected score functions (see Equation 4.3.2)
Eh(b,z)Si(Θ) =
∫ ∞
−∞
1∑
zi=0
Si(Θ)h(bi | yi) dbi
=
∫∞
−∞ Si(Θ)f(yi | bi, zi = 0)f(bi | zi = 0)f(zi = 0) dbi∫∞
−∞ f(yi | bi, zi = 0)f(bi | zi = 0)f(zi = 0) dbi
=
∫∞
−∞ Si(Θ)f(yi | bi, zi = 0)f(bi | zi = 0)(1− p) dbi∫∞
−∞ f(yi | bi, zi = 0)f(bi | zi = 0)(1− p) dbi
can be approximated by
Eh(b,z)Si(Θ) ≈
∑T
t=1
wt√
pi
Si(Θ)f(yi | τˆTi +
√
2xt, zi = 0)∑T
t=1
wt√
pi
f(yi | τˆTi +
√
2xt, zi = 0)
. (4.3.8)
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4.3.2 Maximization Step
Estimation of Parameters in Latent Class
The expected score function for p can be written as
Eb,zSi(p) =
∫ ∞
−∞
∑
z
zi − p
p(1− p)h(bi, zi | yi)dbi.
=
Eb,z(zi)− p
p(1− p)
Solving
∑n
i=1 Si(p) = 0 results in a closed form solution
pˆ =
∑n
i=1Eb,z(zi)
n
,
the estimate of the probability of membership in the unsusceptible class.
Estimation of Class-Specific Parameters
As demonstrated above, parameters in the measurement model and structural
model are only estimated in the susceptible class.
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Estimation of parameters in the structural model
For the estimation of τ , define
Eh(b,z)(Si(τ))
=
∫ ∞
−∞
1∑
zi=0
Si(τ)h(bi, zi | yi,θ)dbi
=
∫ ∞
−∞
1∑
zi=0
(1− zi)Ti(bt − τTi)h(bi, zi | yi,θ)dbi
=
∫ ∞
−∞
(1− 0)Ti(bt − τTi)h(bi, zi = 0 | yi,θ)dbi
+
∫ ∞
−∞
(1− 1)Ti(bi − τTi)h(bi, zi = 1 | yi,θ) dbi
= Ti
∫ ∞
−∞
bih(bi, zi = 0 | yi,θ)dbi − τT 2i
∫
h(bi, zi = 0 | yi,θ)dbi.
(4.3.9)
The first component of Equation 4.3.9 is
∫ ∞
−∞
bih(bi, zi | yi,θ)dbi =
∫∞
−∞ bif(yi | bi, zi = 0)f(bi | zi = 0)f(zi = 0) dbi∫∞
−∞ f(yi | bi, zi = 0)f(bi | zi = 0)f(zi = 0) dbi
=
(1− p) ∫∞−∞ bif(yi | bi, zi = 0)f(bi | zi = 0) dbi
(1− p) ∫∞−∞ f(yi | bi, zi = 0)f(bi | zi = 0) dbi
=
∫∞
−∞ bif(yi | bi, zi = 0)f(bi | zi = 0) dbi∫∞
−∞ f(yi | bi, zi = 0)f(bi | zi = 0) dbi
and
∫ ∞
−∞
h(bi, zi | yi,θ)dbi = 1;
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therefore
Eh(b,z)(Si(τ)) =
Ti
∫∞
−∞ bif(yi | bi, zi = 0)f(bi | zi = 0) dbi∫∞
−∞ f(yi | bi, zi = 0)f(bi | zi = 0) dbi
− τT 2i .
Solving for τ we obtain
τˆ =
∑n
i=1 Ti
∫∞
−∞ bif(yi|bi,zi=0)f(bi|zi=0) dbi∫∞
−∞ f(yi|bi,zi=0)f(bi|zi=0) dbi∑n
i=1 T
2
i
.
Estimation of parameters in the measurement model
Recall that the measurement model specifies the relationships between individual
scale items and the continuous latent variable. The estimation of the α
(j)
k and
βj parameters, thresholds and factor loadings in the measurement model, involves
the expectations of score functions and elements of the information matrix with
respect to the posterior distribution. Expected score functions and second partial
derivatives of class-specific parameters in the MZIPO model can be expressed in
the form
Si(θj) = (1− zi)S∗i (θj).
For zi = 0, the susceptible class,
Eh(bi,zi=0)(Si(θj)) =
∫∞
−∞ S
∗
i (θj)f(yi | bi, zi = 0)f(bi | zi = 0) dbi∫∞
−∞ f(yi | bi, zi = 0)f(bi | zi = 0) dbi
.
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For example, the score function of α
(j)
k is given by
Si(α
(j)
k ) = (1− zi)
[
I[yij = k]
[
Ψ[α
(j)
k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]
Ψ[α
(j)
k − βjbi]−Ψ[α(j)k−1 − βjbi]
]
−I[yij = k + 1]
[
Ψ[α
(j)
k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]
Ψ[α
(j)
k+1 − βjbi]−Ψ[α(j)k − βjbi]
]]
.
If we define
S∗i (α
(j)
k ) =
[
I[yij = k]
[
Ψ[α
(j)
k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]
Ψ[α
(j)
k − βjbi]−Ψ[α(j)k−1 − βjbi]
]
−I[yij = k + 1]
[
Ψ[α
(j)
k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]
Ψ[α
(j)
k+1 − βjbi]−Ψ[α(j)k − βjbi]
]]
then Eh(b,z)(Si(α
(j)
k ) can be approximated using Equation 4.3.8. The remaining score
functions and second partial derivatives (shown in Appendix C) for parameters in
the measurement model can be approximated similarly.
Fisher Scoring Algorithm for Estimation of Parameters in Measurement
Model
For parameters in the measurement model, the solution to Eb,zSi(αj) = 0 is not
available in closed form. Therefore, a Fisher scoring algorithm is used. For the
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estimation of βj, we first consider a Taylor series expansion of the expected score
Eb,zSi(βˆj) ≈ Eb,zSi(βj) + (βˆj + βj) ∂
∂βj
Eb,zSi(βj)
≈ (βˆj + βj)Ii(βj)
because Eb,zSi(βˆj) = 0 and under regularity conditions expectation and differenti-
ation can be interchanged.
Note that
Ii(βj) = − ∂
∂βj
Eb,zSi(βj) (4.3.10)
is the ith individual’s contribution to the observed Fisher information. Taking the
expectation of the observed Fisher information with respect to yi yields
Ji(βj)
= −Eyi ∂∂βjEbSi(βj)
= −Eyi
∫∞
−∞
∑
z
∂
∂βj
Si(βj)h(b, z | yi)dbi
= −Eyi
∫∞
−∞
∑
z
{
∂
∂βj
Si(βj)
}
h(b, z | yi)dbi − Eyi
∫ ∑
z Si(βj)
{
∂
∂βj
h(b, z | yi)
}
dbi
= − ∫∞−∞∑z Eyi { ∂∂βjSi(βj)}h(b, z | yi)dbi − ∫ ∑z EyiSi(βj){ ∂∂βj h(b, z | yi)} dbi
= − ∫∞−∞∑z Eyi { ∂∂βjSi(βj)}h(b, z | yi)dbi.
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Replacing Ii(βj) with Ji(βj) and solving Equation 4.3.10 for βj yields
β
(l+1)
j = β
l
j + J
−1(βj)Eb,zS(βj). (4.3.11)
The individual components in Equation 4.3.11 can be approximated using Gauss-
Hermite quadrature. A similar Fisher scoring algorithm for the estimation of α
(j)
j
is used. For categories k = 0, ..., K − 2
α
(j)(l+1)
kj
= α
(j)(l)
kj
+ J−1(α(j)kj )Eb,zS(α
(j)
kj
) (4.3.12)
and for category k = Kj − 1
α
(j)(l+1)
Kj−1 = α
(j)(l)
Kj−1 + J
−1(α(j)Kj−1)Eb,zS(α
(j)
K−1). (4.3.13)
The components of Equations 4.3.12 and 4.3.13 are approximated using Gauss-
Hermite quadrature. Estimation of the MZIPO model was performed using SAS
9.2 IML.
4.3.3 Predictive validity
An essential step in model checking for any latent class model is the evaluation
of latent class assignment. It is necessary to determine whether the model accu-
rately classifies subjects into unobserved subgroups. Although the MZIPO model
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is estimated using data from the baseline portion of the trial, assessing the pre-
dictive validity of class assignments in the model is performed by comparing the
“gold standard” diagnostic measure for the two latent classes at subsequent time
points in the study. Significant differences in the “gold standard” between the la-
tent classes at time points after baseline indicate the predictive validity of the class
assignment. The differences in the mean of the “gold standard” between the classes
are evaluated with t-tests.
4.4 Example
The motivating example for this chapter comes from the PAL clinical trial. As
described generally in Chapter 1 and more specifically in Chapter 3, a point of con-
tention in lymphedema research is that incidence of lymphedema varies drastically
in the literature, and one explanation is that a variety of diagnostic measures are
used. In addition to swelling, self-reported symptom items such as those in the
Norman Lymphedema Survey (Norman et al., 2001) could potentially be useful in-
dicators of lymphedema incidence or exacerbation. However, in the PAL study the
distribution of self-reported severity symptoms in the Norman Lymphedema survey
was substantially zero-inflated. The PAL trial was designed such that half of the
participants were previously diagnosed with lymphedema and half were not, which
could partially explain the excess of zero responses. However, there is the potential
for undiagnosed lymphedema at baseline as well as the potential for exercise inter-
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vention to bring about lymphedema symptoms. The objective of the analysis was to
use the MZIPO model to identify important Norman lymphedema symptoms and
establish criterion validity compared to objective measures while simultaneously
accounting for the zero-inflation that occurred in the Norman symptoms using a
latent class component.
The sample comes from N = 280 women with complete data from the baseline
portion of the PAL trial. Outcome measures included 7 severity items from the Nor-
man Lymphedema Survey, as described in Chapter 3. Six of the items were chosen
based on results of EFA models (clothing too tight, puffiness, skin feels leathery,
arm feels tired, pain, difficulty writing) and a seventh item (swelling after exercise)
was chosen from the scale as a potential “junk” item. Volume difference percentage
between affected and unaffected arms was considered the “gold standard” diagnos-
tic measure. In contrast to Chapter 3, the continuous volume difference measure
was recoded into seven ordered categories with 5 percentage points in each cate-
gory. This rescaling preserves the linear nature of the “gold standard” measure but
eliminates an identifiability issue in modeling limb volume difference as continuous.
4.5 Results
Frequency distributions for the Norman Lymphedema Survey items are shown in
Figure 4.1 for the full sample. Each item has an excess of zeros, with the percentage
of zeros for each item ranging from 53.24% (N=148) for puffiness to 88.49% (N=246)
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Table 4.1: Baseline characteristics for complete data sample of PAL data.
Stratified by Latent Class
Full Sample (N=278) Susceptible (N=217) Unsusceptible (N=61) P value
Age
Mean, SD 56.13 8.87 56.50 8.92 54.78 8.63 0.1825
Education (Freq., Percent)
High school or less 43 15.47 36 16.59 7 11.48 0.5994
Some college 95 34.17 74 34.10 21 34.43
College or postgraduate 140 50.36 107 49.31 33 54.10
Race
White 183 65.83 136 62.67 47 77.05 0.0592
Black 83 29.86 72 33.18 11 18.03
Other 12 4.32 9 4.15 3 4.92
Marital Status
Never married 31 11.27 24 11.21 7 11.48 0.2585
Currently married/living with partner 168 61.09 125 58.41 43 70.49
Divorced/separated 49 17.82 41 19.16 8 13.11
Widowed 27 9.82 24 11.21 3 4.92
Occupation
Professional 110 40.00 83 38.79 27 44.26 0.0632
Clerical or service 51 18.55 37 17.29 14 22.95
Homemaker, student, or unemployed 25 9.09 16 7.48 9 14.75
Other or unknown 24 8.73 21 9.81 3 4.92
Retired 65 23.64 57 26.64 8 13.11
Dominance
Yes 140 50.36 111 51.15 29 47.54 0.6182
No 138 49.64 106 48.85 32 52.46
Volume Difference
Mean, SD 7.57 13.74 9.60 14.68 0.36 5.13 <0.0001
Lymphedema Diagnosis at Baseline
Yes 133 47.84 126 58.06 7 11.48 <0.0001
No 145 52.16 91 41.94 54 88.52
for difficulty writing. In general there were more moderate responses than slight
responses, but fewer severe and very severe responses than moderate responses. The
potential “junk” item, swelling after exercise, demonstrated a similar distribution
although there were no very severe responses.
Table 4.1 summarizes baseline characteristics, presented for the complete data
sample and stratified by latent class as predicted by the MZIPO model. Average
age for the full sample was 56.13 (SD=8.87), and the majority of study partici-
pants were white (65.83%). About half of the sample (N=140, 50.36%) earned at
77
least a college degree, and the majority were currently married or living with a
partner (N=168, 61.09%). Of the full sample, mean percent limb volume differ-
ence between affected and unaffected arms was 7.57 (SD=13.73). Almost half of
the complete data sample was diagnosed with lymphedema at baseline (N=133,
47.84%), by trial design. Table 4.1 also presents baseline characteristics stratified
by latent class assignment. The MZIPO model estimated that N=61 of the full
sample could be classified as unsusceptible, while N=217 were classified as suscepti-
ble to lymphedema symptoms. Most baseline characteristics were not significantly
different between the two groups with the exception of limb volume difference and
lymphedema diagnosis. Mean volume difference in the susceptible class was 9.60
percent (SD=14.68) while mean volume difference in the unsusceptible class was
0.36 percent (SD=5.13; p <0.001). Among subjects in the susceptible class, 58.06%
(N=126) were diagnosed with lymphedema at baseline compared to only 11.48%
(N=7) in the unsusceptible class (p <0.001).
4.5.1 Ordered Categorical MIMIC Models vs. MZIPO Model
Model results are featured in Table 4.2. This table compares an ordered categori-
cal MIMIC model from the full sample (Model 1), an ordered categorical MIMIC
model where observed non-responders have been removed (Model 2), and finally
the MZIPO model (Model 3). All models include the 7 symptom items chosen from
previous exploratory factor analysis.
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Figure 4.1: Histograms of Norman Lymphedema Survey items for N=278 complete
data sample.
Model 1 yielded particularly high factor loading estimates for clothing too tight
and puffiness (β=6.4971 and β=4.6258 respectively) and moderate factor loadings
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Table 4.2: Ordinal MIMIC model vs. MZIPO model for Norman Lymphedema
Survey items.
Model 1: Ordinal MIMIC Model 2: Ordinal MIMIC Model 3: MZIPO
Full Sample (N=278) Observed Responders Only (N=170)
Proportion unsusceptible (p) NA NA 0.2194
Assoc. with “gold standard” (τ) 0.0707 0.0300 0.0759
Factor loadings (β)
Clothing too tight 6.4971 3.0118 6.4895
Puffiness 4.6258 3.4988 3.8520
Skin feels leathery 2.9493 1.5945 1.9964
Arm feels tired 2.5653 1.3328 1.7772
Pain 1.5514 0.5488 0.9159
Difficulty writing 1.8096 0.8798 1.3618
Swelling after exercise 1.4454 0.2382 0.9583
Thresholds (α)
Clothing too tight
α0 2.3622 -0.6503 1.8536
α1 3.8102 0.5207 3.4778
α2 8.3107 3.9043 8.3723
α3 11.6256 6.7411 13.0676
Puffiness
α0 -0.6084 -3.4946 -1.3867
α1 1.3499 -1.2159 0.6787
α2 4.9343 2.6984 4.0911
α3 8.2182 6.7802 7.5530
Skin feels leathery
α0 2.0497 0.4721 1.4489
α1 2.8585 1.2356 2.1731
α2 4.5022 2.8257 3.7168
α3 6.2383 4.4958 5.2374
Arm feels tired
α0 -0.0228 -1.5520 -0.5056
α1 0.9747 -0.4693 0.4815
α2 3.1981 1.7281 2.5479
α3 5.3502 3.8440 4.5403
Pain
α0 0.8382 -0.1197 0.4623
α1 1.2258 0.2998 0.8297
α2 2.9070 1.9455 2.4726
α3 5.5618 4.4901 4.9728
Difficulty writing
α0 2.3777 1.4241 1.9845
α1 2.5747 1.6366 2.1854
α2 3.7197 2.7146 3.2995
α3 5.6751 4.5897 5.2319
Swelling after exercise
α0 2.0808 1.1561 1.6648
α1 2.5138 1.5614 2.0909
α2 4.0007 2.9965 3.5533
Estimated latent lymphedema severity
Mean, SD 0.1955 0.8264 0.2024 0.8635 0.0922 0.8706
for other items. The smallest factor loading in Model 1 was β=1.4454 for the po-
tential “junk” item, swelling after exercise, but this loading was not much smaller
than the factor loadings for several other items. Factor loading estimates measure
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the strength of the relationship between an individual symptom and the continu-
ous measure of latent lymphedema severity, where larger factor loadings indicate
a stronger association between the item and the latent variable. The estimate of
the coefficient of the regression of latent lymphedema severity on volume difference
for Model 1 was τ=0.0707. As in Chapter 3, this is a global measure of the “gold
standard” on all Norman symptom items. The coefficient can be interpreted as
the average increase in latent lymphedema severity for each 5% increase in volume
difference. The regression coefficient allows us to evaluate criterion validity in that
if there is a strong relationship between the “gold standard” and the set of symp-
toms, this is an indication that these two measures are highly associated with one
another.
In Model 2 the ordered categorical MIMIC model was fit on the subset of the
sample classified as observed responders. Factor loadings from Model 2 were all
smaller than those in Model 1. Consistent with Model 1 results, clothing too tight
and puffiness still produced the highest factor loadings at β=3.0118 and β=3.4988.
One item whose factor loading changed dramatically from Model 1 to Model 2
was swelling after exercise. The smallest loading in Model 2, the factor loading
for swelling after exercise, β=0.2382, was markedly smaller than the factor loading
from Model 1. Furthermore, the estimate of the regression of latent lymphedema
severity on the gold standard, τ=0.03, decreased in Model 2 compared to Model 1.
Finally, Model 3 provides estimates from the MZIPO model. The predicted
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probability of membership in the unsusceptible class was 21.94% of the original
full sample. Conditional parameter estimates from the measurement model were
fit only on the susceptible class, which comprised 78.06% of the sample. Generally,
factor loading estimates for Model 3 were similar to those of Model 1, but most
were slightly smaller. Factor loadings ranged from β=0.915 for pain to β=6.490 for
clothing too tight. The estimate of the regression of latent lymphedema severity
on the “gold standard” was τ=0.076, similar to that of Model 1. One important
difference in Model 3 compared to Model 1 is that swelling after exercise no longer
had the smallest factor loading. This could be an indication that perhaps it is not
truly a “junk” item.
4.5.2 Predictive Validity
In this example, it was clinically useful to determine at baseline subgroups that
might or might not be susceptible to experiencing symptoms over time. Figure 4.2
presents a profile plot of mean volume difference at baseline, 3, 6, and 12 months for
each of the latent classes. In each group, mean volume difference remains constant
over time. However, means between the two classes differ at each time point. T-tests
of volume difference at time points after baseline show that these differences were
significant (p <0.0001). These tests provided an early indication of the predictive
validity of latent class assignment of the MZIPO model.
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Figure 4.2: Profile plot of mean volume difference by predicted latent class assign-
ment.
4.5.3 Evaluation of Observed Zeros and Latent Class Mem-
bership
Table 4.3 presents a cross-tabulation of latent class assignment as determined by
the MZIPO model and observed symptom response. As described in Section 4.2, if
a subject is in the observed response group, she cannot be assigned to the unsus-
ceptible class, so all N=170 subjects with a response were classified as susceptible.
Of the non-responders, 61 were classified as unsusceptible and 47 were classified as
susceptible, despite zero responses on all 7 symptom items.
Table 4.4 presents several baseline characteristics for these three groups. It
was expected that there would be differences among the three groups in terms of
volume difference and baseline lymphedema diagnosis, and these differences pro-
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Table 4.3: Comparison of latent class assignment and observed symptom response.
Observed Symptom Responses
Non-Response Response Total
Unsusceptible 61 0 61
Latent Class
Susceptible 47 170 217
Total 108 170 278
Table 4.4: Characteristics of predicted latent class assignment and observed symp-
tom response.
Stratified by Latent Class and Observed Response
NR/S (N=47) NR/UN (N=61) R/S (N=170) P value
Volume Difference
Mean (SD) 2.45 (7.22) 0.36 (5.13) 11.57 (15.61) <0.0001
Baseline Lymph. Diagnosis
Yes 8 17.02 7 11.48 118 69.41 <0.0001
No 39 82.98 54 88.52 52 30.59
NR/UN=Non-response, Unsusceptible class; NR/S=Non-response, Susceptible class;
R/S=Response/Susceptible class
vide an indication that the MZIPO model does sufficiently well in distinguish-
ing among subjects who are susceptible and unsusceptible. In particular, I ex-
pected the responder/susceptible group to have the highest average volume differ-
ence and greatest percentage of baseline diagnosis among the three groups, and
that proved to be the case. The responder/susceptible group had an average vol-
ume difference of 11.57 (SD=15.61) and 69.41% of that group was diagnosed with
lymphedema at baseline. Of particular interest was the comparison of the non-
responder/susceptible group and the non-responder/unsusceptible group. The non-
responder/susceptible group had an average volume difference of 2.45 (SD=7.22),
compared to 0.36 (SD=5.13) for the non-responder/unsusceptible group. Fur-
thermore, 17.02% of the non-responder/susceptible group and 11.48% of the non-
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responder/susceptible group were diagnosed with lymphedema at baseline. That the
non-responder/susceptible group had a higher mean volume difference and greater
percentage of lymphedema diagnosis at baseline than the non-responder/unsusceptible
provides an indication that latent class assignment is informative in distinguishing
among non-responders.
4.6 Discussion
As in many other applications measuring symptom scales at baseline, data from
the Norman Lymphedema Survey measured at baseline as part of the PAL trial
exhibited zero-inflation in the distribution of scale items. To correct for this, I
developed the MZIPO model, an intuitive model that exploits the use of two types
of latent variables in a single model. Building from recent work in the latent variable
literature as well as the univariate ZIPO model, the MZIPO model allows for the
estimation of a traditional joint latent variable model while accounting for the
presence of excess zeros with a latent class component. If I had employed a ZIPO
model to assess each item separately, this approach would have separated out some
of the observed non-responders. However, this method would not guarantee that the
subgroup removed from the original sample would be the same as if all items were
considered in a model together. In the case of multiple scale items, it was important
to consider not only the relationship between the items and the “gold standard”
diagnostic measure individually, but also the relationship among the items.
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In this chapter, I considered several approaches for the evaluation of multiple
items simultaneously and the evaluation of the relationship between those items
and the “gold standard” in the presence of zero-inflation. The simplest approach
was to fit an ordered categorical MIMIC model on the entire original sample (Model
1). While this approach incorporates all subject information, parameter estimates
may not be entirely accurate because of excess of zeros in the item distributions.
Another approach was to remove all observed non-responders from the sample and
fit an ordered categorical MIMIC model on this subset of the original sample. This
model had the advantage of less skewed item distributions, but in the example of the
PAL trial data almost 40% of the original sample was removed. I advocate the use
of the MZIPO model (Model 3) over a standard ordered categorical MIMIC model.
In the MZIPO model, 21.9% of the original sample was classified as unsusceptible
and therefore not included in the estimation of the conditional parameters in the
measurement and structural components of the model. The MZIPO model allowed
us to account for some of the zero-inflation in the item distributions while still
including useful information on the “gold standard” from more subjects than if all
observed non-responders were removed from the sample. Furthermore, the MZIPO
model provided predicted latent class assignments that could be clinically useful in
predicting lymphedema onset and flare-ups.
The use of the MZIPO model to define latent classes is particularly relevant
to the PAL trial application. Many women do not experience symptoms of lym-
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phedema at baseline, perhaps because they have not been diagnosed with lym-
phedema yet, are unable to identify lymphedema symptoms, or because they are
truly not susceptible to experiencing symptoms. The ability to classify women who
might be susceptible to symptoms at an early stage is essential because these women
may require extra clinical evaluations and careful monitoring for lymphedema on-
set or exacerbation. Therefore, latent classes that exhibit predictive validity could
have great clinical utility. The results from the MZIPO model and evaluation of the
latent classes at subsequent time points in the PAL trial indicated predictive valid-
ity for latent class assignments. T-tests of mean volume difference at time points
after baseline indicate predictive validity of the latent classes, which is significant
because baseline classification into the susceptible or unsusceptible group could be
useful in predicting who is likely to develop lymphedema exacerbations or flare-ups
in the future.
The comparison of baseline characteristics among the 3 observed response and
latent class groups also provides indication of the utility of the MZIPO model. A
particularly interesting group is the non-response/susceptible class group because
this group’s information is included in Model 3 but not Model 2. As shown in the
table, this group had a higher mean volume difference and a greater percentage of
baseline lymphedema diagnosis than the non-response/unsusceptible group. These
differences are an indication that this group was correctly classified into the suscep-
tible class. Even though the subjects in this group did not experience symptoms at
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baseline they may be susceptible to symptoms later on.
In sum, the MZIPO model is a complicated latent variable model and there
are several issues to consider that will require future work. The two most pressing
issues are statistical tests for parameter estimates and the evaluation of model as-
sumptions. First, a means of determining statistical significance for the parameter
estimates is necessary for model comparison. A likelihood ratio test could be a rea-
sonable option to test the regression coefficient in the model without deriving the
complicated standard error formulas necessary for the Wald or Score tests. Further-
more, testing the significance of factor loadings is an ultimate goal that will allow
for added objectivity in the item selection process. Next, simulations are needed
to assess the assumption that the latent class and the continuous latent variable
are independent of one another. This assumption facilitated model estimation, but
in some cases may not be valid. If simulations show that the MZIPO model is
not robust to violations of this assumption, it is possible that the model will have
to be reformulated to allow for the relationship between the latent class and the
continuous latent variable.
In sum, I have shown that the MZIPO model can be a useful tool in determining
the relationship among scale items and between scale items and a “gold standard” in
the presence of unobserved heterogeneity. While more work is required to assess the
practical utility of the MZIPO model, the work presented here illustrates a great
potential for clinical usefulness because of the model’s ability to identify patient
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subgroups that require extra attention.
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Chapter 5
Conclusions
In this dissertation the aim was to investigate the use of joint latent variable mod-
els for multivariate outcomes in order to perform item selection and validation of
symptom scales simultaneously. It has been shown that using joint latent variable
models as an alternative to the typical two-stage process of item selection and val-
idation is preferable because joint models eliminate the bias inherent in estimating
the continuous latent variable. Joint latent variables provide estimates of the rela-
tionship between items in a scale as well as the relationship between the items and
“gold standard” diagnostic measures. These models are particularly flexible as they
accommodate a variety of response types and allow for covariates on the observed
or latent variables.
In Chapter 2, I utilized a joint latent variable model, the MIMIC model, to
simultaneously identify important indicators of PMS severity and to compare these
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indicators to a clinician-rated “gold standard” measure. I developed a Score test
for individual factor loadings in the MIMIC model subject to the model constraint
that factor loadings be non-negative. Using this statistical test I determined that
three items in the PMS symptom scale could be considered for removal from the
scale, which could ultimately improve scale accuracy.
Chapter 3 featured an application of an extension to the traditional MIMIC
model for ordered categorical scale items. This model was applied to data from the
Norman Lymphedema Survey in the PAL clinical trial to evaluate symptom items
at baseline and compare them to a current “gold standard” diagnostic measure.
The ordered categorical formulation of the MIMIC model identified a potential
“junk” item as not statistically significant, providing an indication that this item
could indeed be “junk.” An investigation of the item distributions in the Norman
Lymphedema Survey revealed a substantial amount of symptom non-response at
baseline, which served as motivation for the development of the MZIPO model
proposed in Chapter 4.
In order to account for zero-inflation in the item distributions of the Norman
Lymphedema Scale, in Chapter 4 I proposed a new joint latent variable model
that extended the ordered categorical MIMIC model to incorporate a latent class
component to classify subjects as either susceptible or unsusceptible. The MZIPO
model predicted that 21% of the original complete data sample from the PAL trial
were in the unsusceptible class and provided estimates of factor loadings and the
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coefficient of the regression on the latent measure of lymphedema severity for the
susceptible class. This model was preferable to fitting the MIMIC model on the
complete sample because it reduced the skewness of the item distributions, and it
was also a preferable alternative to simply removing all observed non-responders
from the sample because it allowed more subjects (i.e., all those with information
on limb volume difference) to remain in the sample.
Overall, I have shown in this dissertation the utility of a variety of latent vari-
able methods for scale development. These models have a number of advantages
compared to traditional procedures. First, latent variable models in general can be
considered dimension reduction techniques for multivariate outcomes. Many times
in clinical research a biological process is measured by multiple physical responses,
and latent variable models provide a means of summarizing these measures in a
single model. Next, joint latent variable models in particular can yield greater scale
accuracy and reduced participant burden by identifying the most important indi-
cators of the latent variable and eliminating “junk” information. Finally, in terms
of statistical modeling, using latent variable models for multiple observed outcomes
is advantageous because of the conditional independence assumption that is often
made. This assumption states that given the underlying constructs, the individual
observed outcomes are independent of one another, an incredibly useful assumption
that we took advantage of in order to ease estimation of the MZIPO model.
Although the general use of latent variable methods is highly recommended in
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this dissertation, there are some drawbacks to these types of models that should be
considered. First, the models are highly parameterized. Identifiability is a signifi-
cant hurdle in many latent variable models, and most of the time it is necessary to
place constraints on the model that may or may not be valid in order to get around
this issue. Next, latent variable models require an in depth understanding of the
confirmatory framework among variables. In models such as the MIMIC model
or the MZIPO model, there are strong assumptions made about the nature and
direction of the relationship between observed variables. Using these models ap-
propriately in clinical research requires comprehensive knowledge of the substantive
application. Finally, reproducibility is a critical concern in latent variable modeling.
Factor structures, either in a factor analysis model or in the measurement model of
a joint latent variable, are sometimes not easily reproduced given a different sample.
For this reason, validation is extremely important when using these types of latent
variable models.
Several issues presented in this dissertation warrant further consideration. First,
it is of interest to further investigate the modified Score test for factor loadings in
the MIMIC model presented in Chapter 2. There is a possibility that simulating
data with an association between latent lymphedema severity and the “gold stan-
dard” diagnostic measure induces correlation among the items. If this is the case,
we cannot separately assess the effect of correlation among items and association
between items and the gold standard. In future work I will perform simulations to
93
look at the effect of both of these separately on the performance of the Score test for
a potential “junk” item. Additionally, I will perform simulations to determine how
the modified Score test performs in the presence of non-normally distributed scale
items. If the modified Score test is robust to departures from normality, this will be
another reason why it may be preferable to the traditional Wald test. Furthermore,
in many clinical examples data are less than perfect, so it is important to determine
how a statistical test will behave when scale item distributions are skewed. Overall,
further simulations will provide a better idea of how useful the modified Score test
will be in practice.
In addition to further evaluation of the modified Score test for factor loadings
in the MIMIC model, I will also continue to build on the MZIPO model. After
assessing the model assumptions and deriving standard errors for statistical tests,
as described in Chapter 4, I would like to expand the MZIPO model to include
covariates on the latent class assignment. Extending the model to include covari-
ates will be particularly relevant to applications of the model to clinical research,
where demographic characteristics or comorbidities may influence subgroup classi-
fication. The ultimate goal of this future work is to obtain latent class assignments
that can accurately predict at baseline those subjects who are susceptible to future
lymphedema exacerbations or onset.
In conclusion, the joint latent variable methods that I have proposed and im-
plemented in this dissertation provide flexible approaches for scale development.
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Future research will help to further elucidate the complexities of these methods
with the ultimate goal of producing clinically relevant models that are useful in
practice.
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Appendix A
Derivations for Score Test of
Factor Loadings in MIMIC Model
A.1 Score Function for λ
dl(y; θ)
dλ
=
d
dλ
[
−n
2
ln (|Σ|)− 1
2
n∑
i=1
{(yi − (µ+ λβzi))>Σ−1(yi − (µ+ λβzi))}
]
,
where
d ln (|Σ|)
dλ
=
d ln (|Σ|)
dΣ
?
dΣ
dλ
and ? refers to the star product (MacRae, 1974).
d ln (|Σ|)
dΣ
= [2Σ−1 − Σ−1 ◦ Im]
where ◦ refers to the Hadamard product.
dΣ
dλ
= E(m,1)λ
> + Im ⊗ λ
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so
d ln (|Σ|)
dλ
= [2Σ−1 − Σ−1 ◦ Im] ? [E(m,1)λ> + Im ⊗ λ].
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A.2 Information Matrix
The information matrix for parameters in the MIMIC model is given by
I(θ) = −E d
2l
dθdθ>
=

Iββ Iβµ IβΨ Iβλ
I>βµ Iµµ IµΨ Iµλ
I>βΨ I
>
µΨ IΨΨ IΨλ
I>βλ I
>
µλ I
>
µΨ Iλλ

and we are most interested in the element Iλλ. The second partial derivative with
respect to λ is given by
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Negative Expectation of Second Partial Derivative
From Weller we know that
ABC = B ? {(yi − [µ+ λβzi])(yi − [µ+ λβzi])> ⊗ I(m,m)},
so
E(ABC) = B> ? {(yi − [µ+ λβzi])(yi − [µ+ λβzi])> ⊗ I(m,m)}
= B> ? {Σ⊗ I(m,m)}.
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⊗
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Appendix B
Example Mplus Code for Ordered
Categorical MIMIC Model
TITLE: MIMIC Model for Categorical Data;
DATA: FILE IS example.dat;
VARIABLE:
NAMES ARE item1 item2 item3 item4 item5 goldstandard;
USEVARIABLES ARE item1 item2 item3 item4 item5 goldstandard;
CATEGORICAL ARE item1 item2 item3 item4 item5;
ANALYSIS:
ESTIMATOR=WLSMV;
PARAMETERIZATION=DELTA;
MODEL:
*This specifies the measurement model;
FACTOR1 BY item1* item2 item3 item4 item5;
*This specifies the structural model;
FACTOR1 ON goldstandard;
*This specifies factor variance at 1;
FACTOR1@1;
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Appendix C
Derivations for MZIPO Model
C.1 Score Function
The score function for τ can be written as
∂`τ
∂τ
=
∂
∂τ
n∑
i=1
(1− zi)
[
− ln(
√
2pi)− 1
2
(bi − τTi)2
]
= −1
2
n∑
i=1
(1− zi) ∂
∂τ
(bi − τTi)2
=
n∑
i=1
(1− zi)Ti(bi − τTi),
and the score function for p can be written as
∂`p
∂p
=
∂
∂p
n∑
i=1
zi ln p+
n∑
i=1
(1− zi) ln(1− p)
=
n∑
i=1
zi
p
−
n∑
i=1
(1− zi)
(1− p)
=
n∑
i=1
zi − p
p(1− p) .
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C.2 Information Matrix
Notation and Definitions
Important Derivatives
∂
∂α
(j)
k
Ψ[α
(j)
k − βjbi] = Ψ[α(j)k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]
∂
∂α
(j)
k
Ψ[α
(j)
k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]
= Ψ[α
(j)
k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]2
−Ψ[α(j)k − βjbi]2
[
1−Ψ[α(j)k − βjbi]
]
∂
∂βj
Ψ[α
(j)
k − βjbi] = −biΨ[α(j)k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]
∂
∂βj
Ψ[α
(j)
k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]
= biΨ[α
(j)
k − βjbi]2
[
1−Ψ[α(j)k − βjbi]
]
−biΨ[α(j)k − βjbi]
[
1−Ψ[α(j)k − βjbi]
]2
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